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ABSTRACT

STATE-DEPENDENT MAPPING OF GLYR-CHOLESTEROL INTERACTIONS BY
COUPLING CROSSLINKING WITH MASS SPECTROMETRY

By
Nicholas Ferraro
December 2019

Dissertation supervised by Michael Cascio
The glycine receptor (GlyR) belongs to a superfamily of pentameric ligand-gated ion
channels (pLGICs) that mediate fast neurotransmission. GlyR typically modulates inhibitory
transmission by antagonizing membrane depolarization through anion influx. Allosteric
interactions between the receptor and its lipid surroundings affect receptor function, and
cholesterol is essential for pLGIC activity. Human α1 GlyR was purified from baculovirus infected
insect cells and reconstituted in unilamellar vesicles at cholesterol: lipid ratios below and above
the cholesterol activity threshold with aliquots of azi-cholesterol. State-dependent crosslinking
studies of receptors primarily in its resting (no glycine), desensitized (10mM glycine) and open
(F207A/A288G, 30nM ivermectin) states were then performed at elevated cholesterol levels
necessary for activity. After photoactivation, covalently crosslinked cholesterol-GlyR were
trypsinized, mass fingerprinted by tandem mass spectrometry (MS-MS), and sites of cholesterol
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crosslinks in peptides were refined by targeted MS-MS. Within the GlyR apo state, cholesterol
interactions differed as a function of membrane cholesterol concentration correlating to the
chemical activity of cholesterol, suggesting two distinct conformations. Differential cholesterol
crosslinking patterns between resting, desensitized, and open states were observed, highlighting
state-dependent differences in GlyR lipid accessibility. Distinct state-dependent crosslinking
patterns indicative of alterations in either the lipid environment and/or channel structure were
observed throughout GlyR, most prominently observed in the M4 transmembrane helix,
extracellular domain loops and regions nearing the bilayer interface, and the large intracellular
M3-M4 loop. The changes in M4 accessibility (transition from surface-mapped crosslinking to
regions of the helix less exposed when mapped) suggest an outward twisting motion and
translocation towards the bilayer/lipids as GlyR allosterically transitions. Strikingly, crosslinking
patterns within the M3-M4 loop offer insight into the generalized structure of this unresolved
region in all current pLGIC structural models, by suggesting the crosslinked regions of this
intracellular loop are intimately associated or buried within the lipid bilayer. Taken together,
crosslinking coupled with MS-MS has the capability to accurately probe and define physiological
protein frameworks which can aid in the refinement of allosteric modulation and current structural
models.
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CHAPTER 1: INTRODUCTION

In order to provide a context for the experimental crosslinking mass spectrometry (CX-MS)
studies examining the effect of cholesterol concentration on the structure of the resting state of the
glycine receptor (GlyR)(Chapter 2), and using CX-MS to examine cholesterol-GlyR interactions
in a state-dependent manner (Chapter 3), the dynamics of membranes as a function of composition,
GlyR structure and CX-MS methodology are reviewed in this introductory chapter.

1.1

1.1.1

Membrane Dynamics

Lipid Bilayer Properties
Lipids are vital bioactive compounds that are a major energy reservoir,1 function as

chemical messengers in signal transduction2 as well as protein regulation,3 and are critical for
proper physiological processes.4 Lipids form the structural component of cellular membranes and
their diversity leads to varying microenvironments of a membrane to accomplish a multitude of
functions.5 Bilayers spontaneously come together due to the amphiphilic nature of lipids,
segregating internal cellular components from the outside environment, as the propensity of
hydrophobic moieties within a lipid to self-associate coupled with the tendency of the hydrophilic
head groups to interact with other hydrophilic moieties and the aqueous environment.6

1

In considering phospholipids (Figure 1), there is great diversity in head groups, tail
lengths, and degrees of saturation resulting in over 100 compounds, and when coupled with the
multiplicity of other membrane lipids (Figure 1), leads to a wide range of dynamic physical
properties of cellular membranes.7,8 The lipid’s headgroup (size) and acyl chain (length and
saturation) composition establish its intrinsic properties (shape, occupational space, interactions)
which in turn determines side-by-side packing and the shape of each monolayer creating a net
spontaneous membrane curvature of both inner and outer monolayers. 9 Cylindrical lipids such as
phosphatidylcholine (PC) and phosphatidylserine (PS) promote flat monolayer formation
compared to the conical shape of phosphatidylethanolamine (PE), phosphatidic acid (PA),

Figure 1. Diagram of general lipids. (Left) A general schematic of a phospholipid, with the
hydrophilic region is depicted as consisting of the choline head group, the phosphate linkage,
and the glycerol backbone. The hydrophobic region is depicted with fatty acid chains of
saturation (1) and unsaturation (2). (Middle) A general schematic of a sphingolipid, with the
hydrophilic region depicted as consisting of an amino alcohol linked to a phosphate linked to
the sphingosine backbone. The sphingosine backbone is linked to a fatty acid creating the
hydrophobic region. (Right) A schematic of cholesterol
depicting the polar head group region
2
linked to the hydrophobic region consisting of a rigid steroid ring structure and hydrocarbon
62

diacylglycerol (DAG), and cardiolipin (headgroups smaller than PC) impose negative curvature of
head groups being closer together compared to lipids such as lysophosphatidylcholine and
phosphatidylinositol (larger head group to acyl chain ratio) that promote positive membrane
curvature bending away from headgroups. 10–12 Acyl chain unsaturation (incorporation of double
bonds) induces kinks in the acyl chain disrupting chain packing which causes each individual lipid
to occupy more space than saturated acyl chains, thereby making acyl chain saturation along with
head groups a major factor in the geometry of the membrane, affecting fluidity and melting
temperatures.9 The incorporation of cis-unsaturation reduces close ordering and side-by-side
packing which increases membrane permeability.13 Phospholipid head groups play a significant
role in membrane fluidity and permeability where the strength and relative amount of head group
intermolecular interactions with the hydrophilic environment can influence relative permeability. 14
Membrane lateral pressure is modulated through head group attraction/repulsion, incorporation of
sterols or interfacially active solutes, and by acyl chain length and degree and position of chain
unsaturation.15 Lipid’s influence on cellular function are complex and vary from cell to cell,
making it difficult to generalize lipid modifications on a given system.8

1.1.2

1.1.2.1

Cholesterol Characteristics

Structural Properties
Cholesterol is a major component of nearly all mammalian membranes where its

heterogeneous distribution among organelles, membranes, and leaflets creates diversity in
membrane physiochemical properties and function.16 Derived from a sterane backbone, cholesterol
is a polycyclic amphipathic molecule with a relatively small polar region of a single hydroxyl
3

group linked to a larger apolar section consisting of a four-member ring structure and isooctyl
chain tail (Figure 1, right).17 The polar hydroxyl “head group” is oriented with the aqueous phase
and polar head groups of membrane phospholipids and participates as both a hydrogen bond
acceptor and donor with proximal lipid or protein. This is juxtaposed with the predominant van
der Waal hydrophobic interactions of the aliphatic groups and aromatic π stacking with lipid acyl
chains in the hydrophobic region.17,18 The apolar region of cholesterol is asymmetric with two
distinct faces (α and β), a planar α face and the rough β face defined by the aliphatic methyl groups
and the isooctyl tail allowing for distinct and preferential interactions with each face.19 These
properties enable cholesterol interactions with membrane lipids to exhibit bidirectional modulation
of membrane fluidity, decreasing fluidity of acyl tails above and decreasing fluidity below the gel
to liquid-crystalline phase transition temperature, respectively.20 Cholesterol reduces the rate of
motion of phospholipid acyl chains while increasing the degree of orientation order that leads to
laterally more condensed membranes with increased phospholipid packing density and decreased
membrane permeability.20–22 These unique properties of cholesterol allow for the tight regulation
of a variety of critical cellular functions.23

1.1.2.2

Cholesterol and Microdomains in the Bilayer
Cellular bilayers are laterally heterogeneous with distinct sub-populations present in

leaflets of biological membranes whose distinct interactions drive the association of other lipids
and proteins.24 Cholesterol is essential for lipid raft formation, a localized highly ordered
microdomain within a membrane leaflet of higher cholesterol/sphingolipid/saturated phospholipid
concentration eliciting distinctly less membrane fluidity than the surrounding membrane, where
cholesterol exhibits a higher affinity to partition in the raft phase than non-raft phase.25,26 These
4

dynamic cholesterol-enriched nanoscale domains are essential for key processes such as membrane
trafficking, signal transduction, and protein function where the membrane’s heterogeneity is
critical for specific modulation.27 Proteins partition with lipid rafts at differing degrees and kinetics
where oligimerization, ligand binding, and modifications such as palmitoylation alter a protein’s
affinity to partition within the rafts, allowing for precise regulation of raft composition.26 Lipid
rafts can modulate and respond to protein activation through clustering that concentrates proteins
and/or provides a protected microenvironment for activation/modification to occur, commonly
observed in signal transduction pathways.28 Membrane microdomains modulate dopamine
transporter function where cholesterol-rich membrane fractions promote specific structural
conformations influencing drug binding.29 The partitioning of the serotonin transporter (SERT) in
lipid raft microdomains is critical for serotonin uptake activity and dependent on cholesterol
concentrations.30 Microdomains rich in cholesterol and sphingomyelin modulate several G-protein
coupled receptor (GPCR) functions including signaling, trafficking, and localization. 31 Lipid rafts
are essential for nicotinic acetylcholine receptor (nAChR) membrane trafficking whereby raft
disruption alters cell surface exposure and also stabilizes channels in uncoupled conformations. 32
Taken together, microdomains within lipid bilayers and their dynamic compositions are critical for
the modulation, recruitment, and regulation of membrane proteins. 33

1.1.2.3

Activity of Cholesterol
A given lipid within a bilayer leaflet exhibits diffusion and partitions into different lateral

phases according to relative affinity for the phase with the potential to flip leaflets and redistribute
aqueous region interactions within phases. Therefore, every lipid within the membrane will have
individual “fugacity” or tendency to partition laterally, distribute transversely, and transfer
5

outwardly between condensed lipid phases of varying order. 34 Sterols within lipid complexes can
exceed the threshold complexing capacity and become dispersed in the bilayer characterized by
increased escape tendency.35 Cholesterol in molar excess of the capacity of these complexes has
high fugacity, or termed “active cholesterol”,36 as seen by a abrupt increase in sterol availability to
cholesterol oxidase,37 perfringolysin,38 and methyl-β-cyclodextrin,39 emerging at concentrations
above 25-35 mol percent (typical physiological concentrations).40,41 Excess cholesterol exhibits
high chemical activity in a chemical phase distinct from that observed under negligible chemical
activity.42 Thus, slight variations in cholesterol concentrations about its typical physiological levels
has the potential to drive regulatory processes within or on the plasma membrane surface,43 either
indirectly by modulating plasma membrane physical properties or directly as a protein regulator.20
Phospholipid acyl tail configuration (cis vs. trans unsaturation) alters cholesterol-phospholipid
affinity in which trans unsaturation exhibited lower cholesterol activity than cis counterparts.44
The presence of active cholesterol elicits a variety of feedback response mechanisms including
cholesterol esterification, side-chain oxysterol synthesis, and down-regulation of synthesis through
exportation.35Taken together, cholesterol’s unique structure allows for essential physiological
modulation of lipid bilayers altering physiochemical properties and subsequent components within
the membrane environment.

1.2

Role of Lipids on Protein Activity
The lipid membrane historically has been considered a passive protein-anchoring

environment enabling proteins to mediate cellular functions. More recently, the membrane has
been redefined as a medium that engages directly and specifically with an array of proteins
including channels, transporters, and enzymes.45 Proteins embedded within or contiguous with the
6

lipid bilayer interact intimately with lipids and these interactions modulate their structure and
function.46,47 Minor structural changes to lipids (head group, tail length, and saturation) can alter
the structure and properties of the bilayer, as well as affect protein function via direct binding
interactions, increasing the difficulty to distinguish each specific lipid influence from a diverse
network of membrane lipids.48
It is difficult to accurately differentiate specific protein-lipid interactions (including
hydrogen bonding, hydrophobic effects, and charge interactions) from global membrane
alterations (including fluidity and tension) that influence protein function.47,49,50 In addition to bulk
lipids which have stable dynamic properties, a population of lipids have motional constraints
through interactions either of low affinity hydrophobic surfaces (annular) or high affinity sites in
clefts of protein surfaces or subunit interfaces (non-annular).51 Acyl tail length and head group
variation drastically alters hydrophobic bilayer size and intermolecular interactions critical for the
stabilization of proteins.50 These dynamic interactions of the protein-lipid interface can be within
microdomains of the membrane and are dependent on lipid compositions that modulate either
direct lipid binding/interaction with protein or the physiochemical properties of the bilayer.52–54
Protein activities may be modulated by bilayer properties (thickness and curvature) conversely to
lipid fluctuations (membrane deformation and lipid sorting mechanisms) induced by hydrophobic
mismatch of protein hydrophobic region.55,56 An example of bilayer-induced protein modulation
is bacterial mechanosensitive channels where bilayer tension alters the open state probability of
channels.57 Similarly, the monomer-dimer equilibrium of the amyloid precursor protein is altered
by differential membrane thickness due to varying membrane compositions. 58 A comprehensive
understanding of the influence lipids have at the protein-lipid interface is essential to completely
discern peripheral and integral membrane protein function.45

7

1.2.1

Membrane Proteins
Lipid membrane composition and structure can be targeted to alter localization and activity

of proteins within signaling cascades implicated in diseases like cancer and diabetes.59 An example
of this “membrane lipid therapy” is seen by the modulation of specific interactions of DAG, PS,
and PE with protein kinase C isozymes favoring recruitment into microdomains. 60,61 Thus,
distinguishing complex protein-lipid interactions can offer therapeutic benefits.
The structure and function of membrane proteins can also be affected by specific lipidprotein interactions. For example, the β2-adrenergic receptor dimer interface is stabilized by
cholesterol occupancy.62 Delipidation of interfacial lipids, including cardiolipin, alters oligomeric
stability of Na+/H+ antiporters and bacterial leucine transporter diminishing dimer formation.63
GPCRs localization, activation, and signal propagation are regulated by specific lipid interactions
and membrane composition.61 Similarly, activity of SERT is cholesterol dependent as cholesterol
depletion caused loss of substrate affinity, ligand binding, and transport rate reduction and
recovery of activity required incubation with cholesterol as opposed to other sterols tested
(ergosterol, 5-cholestene, pregnenolone), suggesting essential specific cholesterol interactions.64
Lipids are frequently observed tightly bound to proteins with over 100 unique lipid binding
sites identified in x-ray diffraction, nuclear magnetic resonance spectroscopy, and electron
crystallographic studies, further underlining the importance of specific protein-lipid interactions.65
Annular phospholipid interactions observed in x-ray crystallographic studies of bacteriorhodopsin
show over a dozen tightly bound lipids depicting bilayers exposing protein surface interactions.66
Non-annular lipid interactions are observed in K+ channels and cytochrome bc1 complexes in more
buried regions between adjacent monomers of oligomeric complexes and subunits of multisubunit
8

complexes, respectively. 67 Cholesterol interactions are maintained in structures including the
glutamate receptor,68 Na +,K+ adenosine triphosphatase (ATPase),69 β2 -adrenergic receptor,70 and
dopamine transporter,71 highlighting cholesterol specific interactions of membrane proteins. Taken
together, the presence of a variety of lipids maintained in current structures demonstrates how
essential these molecules are in the stabilization of membrane proteins.

1.2.2

Lipids and Ion Channels
The lipid bilayer and its dynamic composition creates a modulatory environment for ion

channels (including pentameric ligand-gated ion channels (pLGICs)).72–74 Current ion channel
structures including glutamate-gated chloride channel (GluCl),75 K+ channels,76 and Gloeobacter
ligand-gated ion channel (GLIC) 77 reveal lipids bound at both the periphery annulus of the
channel77 and non-annularly.75,76 Agonist binding of GluCl is modulated by select lipids through
binding of membrane-spanning intersubunit crevices potentiating the receptor in an expanded,
open-like conformation.75 Phosphatidylinositol 4,5-bisphosphate regulates inward rectifying
potassium channels, acting as a coupling agent inducing large conformation changes of the
transmembrane domain (TMD)-C-terminal domain association.78
Cholesterol is an essential component of eukaryote membranes, and this specific lipid has
been shown to affect ion channel structure and activity. Cholesterol reversibly affects γaminobutyric acid receptor (GABAR) activity as cholesterol depletion reduces activity and this
can be restored through cholesterol enrichment of cholesterol-depleted neurons.79 A variety of
additional ion channels (inwardly-rectifying K+, Ca2+-sensitive K+, voltage-regulated anion,
vanilloid transient receptor potential channel, voltage-gated K+, voltage-gated Na+, and voltagegated Ca2+ channels) similarly display cholesterol sensitivity, as reduction in cholesterol content
9

in membranes suppresses activity by decreasing open state probability, unitary conductance, or the
number of active channels in the membrane.80 Although decreasing cholesterol concentration
typically down regulates channel activity, a few cases such as G protein inwardly rectifying
channel display up regulation of channel activity during cholesterol depletion.81 Cholesterol and
anionic phospholipids modulate nAChR function where membrane cholesterol enrichment up to a
given threshold (~35 mol%) enhanced receptor-mediated ion flux.82–86 This profound regulatory
effect of cholesterol on nAChR is due to distinct asymmetric cholesterol-dependent conformations,
where the allosteric coupling between neurotransmitter binding sites and the transmembrane pore
is lost, termed the “uncoupled state”, in the absence of cholesterol or anionic phospholipids.87,88
Altogether, lipids play a critical yet unresolved role in ion channel function due to the complexity
of lipid molecules and effects produced to each specific protein.

1.3

pLGIC Channel Allostery

1.3.1 3.1

pLGIC Superfamily Structure

The pLGIC superfamily is essential for rapid neuronal communication through conversion
of a chemical signal to an electrical impulse.89 pLGICs are found in a variety of organisms from
single archaea to several bacteria species and complex vertebrates like humans. 89 pLGICs evolved
from a single ancestral gene to share an overall common architecture which provides an array of
structural models to one another for probing receptor topology. 90,91 Mammalian pLGIC orthologs
are abundant in neuronal networks with regions including neuromuscular junctions as well as
neuronal synapses in the peripheral and central nervous systems. 89 pLGICs are comprised pseudosymmetric arrangement of five subunits forming a central ion-conducting pore.92 The activity of
these channels is generally correlated with the selectivity of this pore as cationic channels such as
10

the nAChR and serotonin receptor (5HT 3-R) are excitatory and anionic such as GABAR, GluCl,
and GlyR are inhibitory.93 pLGICs are known as “Cys-loop” receptors due to a typically
conserved 13 amino acid loop enclosed by a pair of disulfide-bonded cysteine residues within the
extracellular domain (ECD).92,94
All pLGIC subunits share a common global domain organization and common
transmembrane topology,89 with each subunit consisting of a large N-terminal β-sandwich
immunoglobulin-like structure ECD harboring the agonist binding site at the interface of adjacent
subunits, a transmembrane domain containing four membrane-spanning α helices, and an
intracellular domain (ICD) consisting of largely heterogenic transmembrane helix connecting
loops (Figure 2).93,95,96

Figure 2. pLGIC GlyR pentamer. Multiple GlyR topology views of cryo-electron microscopy zebrafish GlyR

structure (PDB #3JAD) adapted from Du et al. (2015).100 The large globular ECD includes Cys-loop and ligand
binding domain (see side view and top-down).TMD helices form the central pore (see bottom-up view). The M3M4 loop and the C-terminal tail are removed.

11

Most eukaryotic pLGICs are heteromeric assemblies, with multiple homologous subunit
species within a single pLGIC labeled α, β, γ, etc, which are further divided into subtypes: α1, α2,
etc.93 Recent structures of both prokaryotic (Erwinia chrysanthemi ligand-gated ion channel
(ELIC),97 GLIC98 and eukaryotic (GluCl,99 GlyR100) channels show high conservation of the
structures of both the ECD and TMD comprising of the majority of the channel (Figure 2). The
minimally characterized intracellular M3-M4 loop region is least conserved among pLGICs having
a wide range of sequence length and divergence.101 Therefore, it is typically removed or truncated
in most pLGIC models due to the increased heterogeneity and lack of structural stability making
it difficult to generate sufficient resolution.96

1.3.2

pLGIC Superfamily Function and Significance
Electrochemical gradients consist of two driving forces of ion movement across a

membrane: an electrical driving force and a chemical (concentration) driving force.102 The
electrical drive force contributing to the membrane potential arises when the electrical charge on
two sides of a membrane differ due to unequal amounts of charged ions.18 The chemical or
concentration driving forces arises due to asymmetric concentrations of each ion on both sides of
a membrane. Together these forces create an electrochemical gradient, with the reversal potential
(also known as the Nernst potential) occurring when no net flow of a particular ion occurs.18,102

12

The pLGIC superfamily contributes to all central nervous system functions that include sensory
and motor processing, central autonomous control, memory, attention, sleep, wakefulness, reward,
pain, anxiety, emotions, and cognition.103 Channel activation involves long range allosteric
conformational rearrangements initiated by ligand binding that propagates movements ultimately
disrupting the permeation gate, producing a transient open, ion-conducting channel (Figure 3).104
Passive movement of ions down their electrochemical gradient alters the membrane potential
affecting the resting potential across the membrane allowing rapid movement of ions across an
otherwise

impermeable

hydrophobic

membrane,

endowing

millisecond

cellular

communication.105,106 Influx of cations (Na +, K+, Ca2+) typically depolarize membrane potential
while anion (Cl-) influx induces membrane hyperpolarization.107 Continued presence of bound
ligand causes further structural rearrangements to a long-lived non-conducting desensitized state
refractory to further activation.104,108 Channels recover from desensitization relatively slowly,
transitioning to apo-structures that can be ligand-activated and continue the thermodynamic
cycle.109

Figure 3. Major ion channel states. Simplified cartoon depiction of allosteric transitions from the apo-state
(Resting/Closed) to the ligand-bound ion conducting state (Open) to the ligand-bound non-conducting state
(Desensitized).257
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The pLGIC superfamily’s ability to modulate neuronal and muscular activity coupled with
their sensitivity to a variety of drugs has made this superfamily of ion channels attractive and
significant pharmaceutical targets.110 pLGICs are targeted by drugs such as nicotine, alcohol,
cannabinoids, and benzodiazepines.93,111 Both nAChRs and 5-HT3Rs are major targets in drug
discovery for several psychiatric, neurological, and peripheral disorders, leading beyond clinical
trials to marketed drugs. 112,113 Additionally, pLGICs malfunction are implicated in serious
conditions such as Alzheimer’s disease,114 Parkinson’s disease,115 epilepsy,116 smoking
addiction,117 and alcohol dependence.118

Defects in GlyR activity underlie pathological

mechanisms of various neurological diseases such as startle disease (hyperekplexia) where
missense mutations in genes encoding GlyR subunits cause glycinergic dysfunction leading to the
neurological disorder.119 Inadequate clinical efficacy and adverse side effects occurring in
gastrointestinal and the central nervous system (CNS) are the major current barriers in therapeutic
strategies, emphasizing the necessity for discovery and refinement of therapeutic small molecule
modulators.112 Further refinement of allosteric ion channel structure at drug interaction is essential
for the understanding of the nature of specific drug action onto the pLGIC therapeutic targets.95

1.3.3

GlyR Allostery
The inhibitory GlyR is comprised of α (α1-4, ~48 kDa) and β (β1, ~58 kDa) subunits that

typically assemble pentamerically at a 2α:3β ratio.120 Functional homopentameric α subunit
channels can be overexpressed for biochemical and biophysical characterization,121 however β
subunits are required for physiological postsynaptic clustering due to high affinity binding of its
M3-M4 loop regions with gephyrin scaffolding.122 Each subunit ECD contains the characteristic
Cys-loop within a ten strand β-barrel-like (β1-10) structure with two short α-helices connecting β3
14

and β4.123 Glycine ligand binds at the interface of two adjacent subunits in the ECD, and this
neurotransmitter binding site is located between three loops “A-C” of the principal subunit and
three β strands (β1,β2, and β5) of the complementary subunit.100,123 Upon glycine binding, GlyR
allosterically transitions to a transient open conformation, where channels become permeable to
small anions such as chloride, resulting typically in Cl--influx and hyperpolarization.124 The TMD
of GlyR (M1-M4) is connected by extracellular (M2-M3) and cytoplasmic (M1-M2, M3-M4)
loops where M2s forming the central ion pore flanked by M1/M3, and M4 associated with M1/M3
most distant from the pore (Figure 4).125 The channel gate(s) corresponds with the narrow channel
pore region(s) at residues near the TMD:ICD interface critical for charge selectivity whereby
residue side chains help control the electrostatic environment and create selectivity filters.106,126
The TMD connecting loops, specifically the M1-M2 and M2-M3 loops flanking M2, interact with
proximal regions of the ECD/ICD including the ligand binding domain and are also involved in
channel gating.127,128 The eighteen length amino acid binding site of gephyrin,129 as well as
endocannabinoid interactions130 with GlyR, are mapped to the M3-M4 loop. Immediately
downstream of transmembrane helix M3 within the loop resides a cluster of basic residues
containing topological information imperative for localization.131

15

Figure 4. GlyR single subunit structure. Simplified diagram of GlyR single subunit, illustrating domains of the
subunit.258 The extracellular domain features both N- and C- termini, a large pre-M1 globular region, and the M2M3 loop. The transmembrane is comprised of M1-M4 α helices. The intracellular domain consists of the M1-M2
loop and M3-M4 loop.

1.4

1.4.1

pLGIC Pharmacology

Pharmaceutical Agents and Bioactive Lipids
An array of pharmaceutical agents (anesthetics, barbiturates, benzodiazepines,

cannabinoids, and alcohol) and bioactive lipids (progesterone, sphingomyelin, and ceramide)
specifically targets the pLGIC superfamily of ion channels.111,132–134 Anesthetics generally
potentiate inhibitory anion-permeable channels while inhibiting excitatory cation-permeable
channels, observed in the general anesthetic propofol enhancement of GABA and GlyR agonistinduced activation with inhibition of 5-HT3R and nAChR channels, however the molecular
mechanism of channel modulation remains unresolved.135,136 In a similar manner, barbiturates
modulate a variety of neuronal receptors both cationic (including α-amino-3-hydroxy-5-methyl-4isoxazolepropionic acid receptor, kainite receptor, nAChR, and 5-HT3R) and anionic (including
16

GABA, and GlyR) through inhibition and enhancement, respectively. 137 Endocannabinoids are
direct GlyR allosteric modulators with both positive and negative modulation based upon
endocannabinoid subtypes with Δ9 -tetrahydrocannabinol exhibiting positive modulation,
highlighting relevant cannabinoid-induced analgesia strategies in pain therapeutics. 130 At least
GlyRs and GABARs of the pLGIC superfamily demonstrate sensitivity to allosteric modulation
by n-alcohols (ethanol and butanol) that bind/interact in generally hydrophobic pockets/regions of
which are closely associated or within the lipid membrane.138,139
Bioactive lipids also play a diverse role in modulating pLGIC activity. Amongst their
effects are regulation of cell-surface nAChR levels,134 the inhibition of GABAR,133 and the
modulation of nAChR desensitization.140 Lipoprotein(a) is linked to the generation and
maintenance of pain by modulating ion channel/receptors signaling pathways and gating properties
through specific direct interactions.141 Cannabinoid-like GlyR potentiator screening providing an
effective tool to discover novel interactions, 111 highlighting the necessity to develop methodologies
that accurately probe and refine protein-lipid interactions. Collectively, there are at least 170
compounds (psychiatric medications, anesthetics, anticonvulsants, natural extracts, amino acids,
ions,

endogenous

substances,

drugs

of abuse,

and

miscellaneous

medications)

of

electrophysiological studies that can promiscuously modulate a subpopulation of LGICs (GABA,
nAChR, GlyR, and 5HT 3) suggesting extensive interactions that require characterization to not
only increase efficacy but to also provide templates to guide drug development.142 Intriguingly,
both anesthetics and bioactive lipids partition with the cellular membrane specifically at the lipidprotein interface,143,144 with anesthetics observed in crystal structures of pLGIC structural
homologues,145,146 providing tremendous opportunity to discern molecular mechanisms of pLGIC
allostery.135
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1.5

1.5.1

Photocrosslinking Coupled with Tandem Mass Spectrometry

Crosslinking Studies
Hundreds of thousands of protein interactions stemming from approximately twenty

thousand protein-encoding genes create a dynamic protein-protein interactome network
underlying all biological processes.147 The elucidation of these vast diverse networks provides
insight into protein regulation and function. 148 The majority of proteins function through complex
assemblies including dynamic non-covalent associations of individual proteins, highlighting the
potential to link interactions at a longer time scale.149 A novel method of elucidating protein
interactions within networks is through protein crosslinking comprised of chemical, enzymatic, or
chemoenzymatic formation of covalent bonds between polypeptides. 150 By introducing a stable
chemical linkage, transiently associated species establish a permanent interaction that previously
would be difficult to detect and define.151
Crosslinking

occurs

naturally through

enzymatic-catalyzed linkages

seen

by

transglutaminases, sortases, and lysyl oxidases in various protein matrices. 150 General crosslinking
to immobilize protein environments within cells is commonly completed using formaldehyde, an
efficient cell-permeable small compound creating DNA-protein, RNA-protein, and protein-protein
crosslinks. Glutaraldehyde is one of the most effective and commonly used crosslinking reagents
due to the variety of different forms of the compound yielding a vast range of suitable conditions
like pH, temperature, and concentration, making it one of the most efficient crosslinkers for protein
and enzyme immobilization.152 The amine-reactive N-hydroxysuccinimide esters are sensitive to
primary amines, namely lysine residues, making it an effective crosslinker to proteins in living
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cells allowing the probing of three-dimensional structures.153 Maleimide-based crosslinkers react
rapidly to sulfyhydryl groups with minor reactivity with amino groups, allowing for intramolecular
crosslinking of protein subunits.154 Given the variety of approaches for in vitro and in vivo
crosslinking

utilizing

multifunctional

crosslinkers

(including

homobifunctional

and

heterobifunctional) with varying length and reactive groups generates enormous diversity of
available crosslinking reagent-based methodologies.150
Photoaffinity labels offer reproducible labeling in time- and location-specific manner in
the presence of ultraviolet light to the target protein. 155 Photoaffinity labeling features a lightsensitive reactive motif for covalent linkage and commonly employed in drug discovery, drug
target binding, and protein-ligand interactions having the advantage as useful tools in live cells
and physiologically relevant systems to convert transient short-lived interaction into permanent
covalent bonds amenable to a variety of analysis techniques.156,157 Azide photocrosslinking (Figure
5, Right) chemistry is commonly used to obtain structural constraints in biological systems through

Figure 5. Photoreactive crosslinkers. Two examples of many photocrosslinkers available. The
diazirine motif (Left) creates carbene intermediates for concerted addition reactions. The azide
motif (Right) creates nitrene intermediates for addition reactions.259
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formation of reactive nitrene intermediates targeting primarily C-H and C=C bonds for addition
reactions, characterizing the higher order structure of RNA and RNA-protein complexes.158,159
Benzophenone crosslinkers typically react with unreactive C-H bonds having mapped nucleotidebinding sites in ATPases and confirmation flexibility in solution, micelles, and membranes. 160 In
particular, diazirines (Figure 5, Left) are commonly utilized photoreactive probes to study ligandreceptor, ligand-enyzme, and protein-protein interactions.161

1.5.2

Mass Spectrometry
In modern proteomics, mass spectrometry is increasingly utilized and rapidly advancing

the variety of approaches and instrument resolution to elucidate cell protein compositions, complex
formation, stoichiometry, architecture, and dynamics.162 The application of mass spectrometry to
proteomics is the use of one or more techniques from a collection of methodologies (sample
preparation, chromatography systems, mass analyzers) where each can have particular strengths
suited to specific investigations, all based upon the measurement of mass-to-charge ratios of gasphase ions.163,164 In general, analyte enters the ionization source where molecules are converted to
the gas phase and ionized, directed into a variety of mass analyzers separating ions based upon
mass-to-charge ratios through modulation of electric and magnetic fields, ultimately reaching the
detector to be measured (Figure 6).164,165 Advances in modern mass spectrometry have lead to the
development of methodologies achieving extraordinary mass accuracy (>2ppm), resolving power
(>100,000), and limit of detection (sub-nanogram).166,167
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Figure 6. Quadrupole time-of-flight schematic. For tandem MS experiments, ions from the
source enter and are filtered through the quadrupole, enter the collision chamber for
fragmentation, and finally enter the time-of-flight tube for ion separation before reaching
the detector.260
The implementation of tandem mass spectrometry (MS-MS) analysis has become an
essential tool in the analysis of protein identification, complex structures, and protein
modifications, where precursor ions are selected, activated through energetic collisions with
neutral gas causing dissociation into product ions that reveal additional information about the
protein, complex, or analyte assayed.168–170 For protein and peptide based MS analysis, the most
commonly employed ionization sources for mass spectrometers are soft ionization methods
including matrix assisted laser desorption ionization and electrospray ionization (ESI) that can
preserve native structure and complexes entering the mass spectrometer which are then
discriminated typically by quadrupole, time-of-flight, or ion trap analyzers with the inclusion of
collision cells for fragmentation.171
Given the sample’s potential complexity, the implementation of high performance liquid
chromatography (HPLC) preceding mass spectrometry increases the dynamic range and
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Figure 7. Collision-induced fragmentation pattern. Diagram of CID product ions produces after
precursor ion fragmentation. CID typically produces “b” and “y” ions with less occurring “a”
ion production.261
identification coverage of analyte through separation based upon analyte interactions with
chromatographic stationary and mobile phases.172 In determining protein complex composition,
the dissociation of subunits follows a predominant fragmentation pathway with the expulsion of
mono/multimeric protein subunits sequentially from the now stripped complex, allowing for the
elucidation of subunit organization and stoichiometry. 169 Varying dissociation pathways in
response to increased collision-induced dissociation (CID) energy are observed in peroxiredoxin
ring assembly MS studies where dimers preferentially associate as intermediate pentamers, 6-mers,
and 8-mers, with subunit dissociation as dimers opposed to monomer dissociation.173 The MS-MS
peptide dissociation pathway using CID provides reproducible fragmentations typically through
cleavage of an amide bond (denoted as “b” ions if charge retained on N-terminus fragment and
“y” if retained on C-terminus fragment) in the peptide providing information regarding the specific
order of amino acids in smaller fragments stemming from the original peptide (Figure 7).174,175
This is commonly employed in protein sequencing or modification assays where MS-MS
fragmentation produces unique product ions that are compared with potential sequence masses in
secession and/or refines the targeted modification location from a peptide to potentially single
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amino acid resolution.176 Advances in MS instrumentation have allowed for the analysis and
identification of low abundant crosslinked peptides from complex biological samples providing
more comprehensive and complete information for studies. 177

1.5.3

CX-MS as a Biochemical Tool
Current CX-MS strategies capture both the identity and connectivity of protein-protein

interactions from their native cellular environment. 177 The incorporation of sensitive MS-based
approaches to photocrosslinking workflows allows for the potential to not only map proteinprotein interactions but also identify allosteric dynamics of protein structure and interactions with
its environment.178,179 The transient nature of protein dynamics, exemplified in neuronal receptor
allostery, typically poses a challenge for characterization, however the approach of using
photocrosslinking provides a dynamic representation of protein alterations including receptor
gating and desensitization.179,180 Crosslinking reagents are of a defined length resulting in distance
constraints (shortest distance between linked amino acids given protein volume) essential for
structural validation, modeling, and de novo prediction.177
Photoaffinity labeling coupled with modern MS instrumentation can provide additional
structural and mechanistic information compared to other photolabeling techniques regarding
protein complexes, ligand-receptor stoichiometry, binding pocket maps, and single amino acid
binding resolution.181 CX-MS is rapidly advancing becoming a promising approach to gain
structural information on large, potentially transient protein assemblies, intrinsically disordered
proteins, and protein interaction networks both in vivo and in vitro.182 Current tandem MS
instruments have the mass accuracy and sensitivity to unambiguously identify and refine
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crosslinked species to amino acid residue(s) within a given peptide.178,183,184 CX-MS has be used
to guide complementing structural techniques like crystallography in protein complex
crystallization and conversely employed to verify and refine pre-determined crystal structures.185
Interaction networks of mitochondrial proteins analyzed in vivo generating mitochondrial
interactomes highlight capabilities where native molecular environments need to be maintained. 186
CX-MS in conjunction with computational modeling elucidated a comprehensive proteinprotein interaction network of proteasome complexes generating nearly 500 linkages of both interand

intra-protein

interaction

highlighting

structural

dynamics

and

conformation

heterogeneity.177,187 The ability of coupling additional quantification techniques to CX-MS studies
to not only identify specific interactions but report the frequency of interactions, observed in
calmodulin quantification of substrate interactions which determined the abundance of complex
formations, demonstrating the ability of crosslinking to be quantified by traditional calibration
curve or isotope dilution methods.188,189 Photoaffinity labeling coupled with MS has the capability
to map lipid accessibility of proteins and protein:lipid interactions elucidating the propofol binding
site of GLIC190 and GABAR191 as well as cholesterol interactions with the peripheral-type
benzodiazepine receptor (PBR),192 voltage-dependent anion channel-1,193 nAChR,194,195 and
GlyR.178 The coupling of these techniques highlights the advantages of providing more
comprehensive information of greater detail, sensitivity, and less analysis times than traditional
biophysical labeling techniques.181

1.5.4

Advantages and Limitations
The most basic and essential advantage of CX-MS is the generation of covalent bonds

between target protein/lipids that can by highly specific and of high capacity, stabilizing a long24

lived association amenable for analysis.196 An essential benefit of in vivo CX-MS is to characterize
structural information (cellular compartmentalization, concentrations, interacting partners) within
native environments at or near physiological conditions.197 CX-MS assays can be a quick and
convenient approach that does not require a large amount of protein or at high purity and is
applicable to a variety of proteins and protein complexes after minor affinity purification.198 In
most cases, the performance of CX-MS does not depend on the length, size, or tertiary structure
of proteins being beneficial in analysis of large proteins and disordered regions of proteins. 198
Taking advantage of MS exquisite accuracy and resolution, CX-MS studies have the
ability to unambiguously identify crosslinks within proteins upon fragmentation to refine the
modification site.199 For substrate binding studies compared to computational methods, CX-MS
does not require prior structural knowledge or information of the protein or binding site of
interest.198 Multifunctional crosslinkers offer users the ability to select the initial attachment
allowing for precise positioning of the crosslinker within the protein for improved crosslinker
functionality.200 Comprehensive structural data can be additional acquired through the combination
of varying lengths crosslinkers within single experiments. 201 Targeted quantitative CX-MS of
crosslinked peptides accurately quantifies dynamic changes in protein structure, complexes, and
interactions or varying experimental conditions and biological states, allowing for state-dependent
mapping of protein-protein or protein-lipid interactions.202
One of the most prominent limitations of CX-MS studies is the requirement of highresolution mass spectrometry instrumentation coupled with an efficient enrichment process of
desired crosslinks given the low population of crosslinks within complex samples.203 CX-MS can
generate uneven distribution of crosslinking within a protein structure influenced by enzymatic
digestion site distribution.201 A limitation of CX is that crosslinkers generate artificial crosslinks
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more prominent with longer crosslinker spacers, requiring greater effort of independent validation
of identified crosslinks.196 Crosslinker:protein ratios are kept low to avoid structural perturbations
including crosslinker-induced polymerization.203
When targeting specific regions of protein/complexes, the crosslinker must be accessible
to the desired site(s) of interest to interact and provide information.150 Distance constraints crested
through current crosslinkers may not have the resolution to resolve structural arrangements such
as β-sheets.201 A restriction or bottleneck of CX-MS studies arises during MS data analysis due to
the lack of automated algorithms and programs to process both MS and MS-MS spectra limiting
throughput stemming from the large diversity and uniqueness of individual assays as well as highly
complex spectra with low signal intensity.204

1.6

1.6.1

Cholesterol-GlyR Interactions

Rationale
Lipid interaction studies with nAChR83,86 demonstrate the requirement of cholesterol in

bilayers for ion channel activity and asymmetric interactions based upon concentration.
Cholesterol concentrations (>25 mol% and 40 mol%) were selected given cholesterol’s activity
threshold of ~33 mol%40 coupled nAChR activity studies showing enhanced cholesterol-mediated
ion flux up to ~35 mol % cholesterol membrane content,86 correlating both lead to the hypothesis
that if cholesterol crosslinking was used to analyze cholesterol accessibility to GlyR under both
concentrations (<25 mol% and >40 mol%), the cholesterol accessibility/crosslinking pattern of
<25 mol% would be entirely contained within the pattern of cholesterol accessibility/crosslinking
of >40 mol% with additional crosslinking solely observed in the >40 mol% studies. Conversely to
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traditional binding site studies, the <25 mol% crosslinking is hypothesized to be non-specific
random interactions due to cholesterol’s negligible activity while the >40 mol% crosslinking is
hypothesized to be a collection of both non-specific interactions (observed in <25 mol% studies)
and specific interactions unique to the elevated cholesterol condition.
It is hypothesized that azi-cholesterol-GlyR CX-MS studies can provide state-dependent
differential crosslinking patterns that capture dynamic structural information about individual and
distinct GlyR conformations. pLGICs including GlyR display distinct allosteric state
conformations and when coupled with the ability to stabilize GlyR in the resting, open, and
desensitized states allow the interrogation of state-dependent cholesterol interactions. This CXMS study can not only elucidate concentration- and state-dependent effects on the GlyRcholesterol interaction profile, but also reveal structural information (lipid accessibility through
bilayer proximity and/or hydrophobic pockets) about unresolved portions of GlyR (M3-M4 loop
and C-terminal tail). It is hypothesized that crosslinking identified in open state studies is a
combination of crosslinking from channels sampling both resting- and open-like conformations
and that crosslinking uniquely identified in open-state datasets are representative of the open state
confirmation. Similarly, it is speculated that crosslinking identified under desensitizing conditions
is a collection of crosslinking from channels sampling the resting, open, and desensitized
conformations. Comparative studies can similarly be used to find unique crosslinks not observed
in resting and open-state studies, such that crosslinking can be attributed to the desensitized
receptor.
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1.6.2

Experimental Overview
Given the essential, yet undefined role of cholesterol’s modulation of pLGICs as well as

other membrane proteins, we examined cholesterol accessibility of homomeric α1 GlyR in a
concentration- and state-dependent manner using CX-MS. CX-MS concentration-dependent
studies were conducted on apo-state GlyR at <25 mol% and >40 mol% cholesterol content within
the lipid membrane. Resting state studies, performed previously178 using WT apo-GlyR stabilize
channels in a unbound, non-conducting manner. Azi-cholesterol, a photoactivatable cholesterol
analog non-specific probe, was used to covalently capture cholesterol-GlyR interactions with equal
incorporation into both concentration studies (<25 mol% and >40 mol%). To further define
cholesterol’s role in pLGIC modulation and expand on the apo-state GlyR studies, state-dependent
cholesterol crosslinking was conducted on GlyR in conditions stabilizing the open and desensitized
states at >40 mol% cholesterol in the lipid membrane. Open state studies were completed on a
doubly mutant (F207A/A288G) GlyR in the presence of ivermectin (30 nM) yielding an
ivermectin-sensitive non-desensitizing channel.205 Desensitized state studies were conducted in
the presence of saturating concentrations of glycine, stabilizing WT GlyR in a higher-affinity
ligand-bound desensitized conformation. This study shows that photocrosslinking coupled with
tandem MS can map a lipid-protein interface in several allosteric states/conformations, depicting
lipid accessibility during transient structural changes. Direct cholesterol-GlyR interactions have
been

identified

in

different

allosteric

conformations

that

can

help

refine

GlyR

crystallographic/cryo-electron microscopic models, principally in unresolved regions, provide
insight into ion channel dynamics of gating and desensitization.
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CHAPTER 2: APO-STATE CHOLESTEROL-GLYR INTERACTIONS

2.1

Abstract
GlyR belongs to a superfamily of pLGICs that mediate fast neurotransmission. GlyR

typically modulates inhibitory transmission by antagonizing membrane depolarization through
anion influx. Allosteric interactions between the receptor and its lipid surroundings affect receptor
function, and cholesterol is essential for pLGIC activity. Cholesterol at compositions below ~33
mol percent has been shown to have negligible chemical activity, suggesting that specific
interactions between membrane proteins and cholesterol become significant only at concentrations
above this stoichiometric threshold. Human α1 GlyR was purified from baculovirus infected insect
cells and reconstituted in unilamellar vesicles at cholesterol:lipid ratios above and below the
cholesterol activity threshold with equivalent aliquots of azi-cholesterol, a photoactivatable nonspecific crosslinker. After photoactivation, crosslinked cholesterol-GlyR was trypsinized and mass
fingerprinted. Mass shifted peptides containing cholesterol were identified by ESI-Q-TOF MS,
and sites of direct covalent attachment to peptides were refined by targeted MS-MS. Differential
patterns of dozens of cholesterol-GlyR crosslinks were identified in these comparative studies,
with sites of crosslinking found primarily in the fourth transmembrane helix and extramembranous
connecting loops and mapping the lipid-accessible surface of the receptor. Unique crosslinking
observed in both reduced and elevated cholesterol composition suggests different apo-state
structural conformations of GlyR as a function of cholesterol concentration and, in the latter
studies, identified potential specific binding sites for cholesterol in the receptor.
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2.2 Introduction
The current model of the biological membrane suggests lipids and proteins are not
homogeneously distributed and form microdomains, with cellular processes at membranes
modulated as a function of its composition.52 Lipid composition alters the physicochemical
properties of the bilayer, and this local environment may modulate the structure and function of
membrane proteins.53,54 Striking examples of these effects include the different topologies
exhibited by lactose permease as a function of phospholipid composition,206 the abrogation of
dimer formation of the leucine transporter from cardiolipin delipidation,63 the lipid dependence of
glucose transporter activity,207 and the effects of cholesterol on ion channels and other membrane
proteins.80,208,209 Crystallographic studies have further highlighted the importance of these
interactions as structures often contain specific bound lipids. 65 For example, cholesterol has been
co-crystallized with G-protein coupled receptors,65 Na+,K+ ATPase,69 and the dopamine
transporter.71
Sterols preferentially associate with increasing acyl chain saturation of phospholipids and
with sphingolipids, forming complexes and microdomains that target the transmembrane regions
of some proteins.210,211 Cholesterol in molar excess of the capacity of these complexes has high
accessibility and fugacity, and will be referred to as “active cholesterol”.36 Above this
stoichiometric threshold

there is a sharp increase in sterol availability to cholesterol oxidase,

perfringolysin, and methyl-β-cyclodextrin.37–39 Sterol availability typically emerges at
concentrations above 25-35 mol percent and at lower concentrations it has negligible chemical
activity.40,41 Membrane–intercalating amphihiles can activate cholesterol by displacing cholesterol
from its lipid complexes.212 Consistent with these observations, cholesterol activity increases in
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the presence of sphingomyelinase.213 Taken together, significant specific cholesterol-protein
binding is expected to emerge only at higher cholesterol concentrations.
The interactions between pLGICs, the superfamily of ion channels that are essential for
fast neuronal signaling between cells, and the surrounding lipids influence their function.72,73
Lipids are proposed to allosterically modulate GluCl by inducing an expanded open-like
conformation and by potentiating agonist binding.75 Both depletion and enrichment of membrane
cholesterol reduced efficacy of GABAR channel activation.79 Cholesterol and anionic
phospholipids have been shown to be a key modulator of nAChR function and critical for
conformational transitions between allosteric states.82–84 In reconstituted lipid vesicles lacking
cholesterol or phosphatidic acid, agonist fails to stimulate nAChR ion flux. 85,86 Increasing
cholesterol/phosphatidic acid concentration within the lipid environment enhances nAChRmediated ion flux and was found to saturate at ~35 mol percent cholesterol and ~12 mol percent
phosphatidic acid.86 Below this concentration, nAChR favors a desensitized-like uncoupled state,
while approaching and exceeding this threshold favors the resting state, which has the ability to
undergo agonist-induced conformational transitions.214
A novel way of gaining structural information to further understand protein-lipid
interaction is through the use of chemical crosslinking.215 Photoaffinity labeling studies directly
identified the propofol-binding site of GLIC190 and GABAR.191 Cholesterol homologs were
similarly used to map sites of cholesterol interactions with the PBR and putative cholesterol
recognition amino acid consensus (CRAC) motifs were identified. 192 Cholesterol photoaffinity
probes have also characterized lipid-protein interactions of cholesterol and nAChR.194,195 In these
studies, azi-cholesterol bound extensively to the M4 region within nAChR (~75%), as compared
to the M1 and M3 segments (~25%), with binding regions congregated toward charged amino
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acids located at the ends of the M4 segment, leading researchers to question whether peptide
labeling is driven by proximity of the azi-cholesterol or by diffusional encounters with accessible
side chains.194 The advent of MS methodologies offers the opportunity to more sensitively and
specifically detect and map covalent crosslinks with lipids.
Given the essential, yet not completely defined role of cholesterol’s influence of
membrane protein structure and function, we propose to examine the cholesterol accessibility of a
paradigmatic pLGIC as a function of cholesterol concentration in comparative studies above and
below its “activity” threshold. In this study we have focused on identifying non-specific
(cholesterol at low mol percent) and specific (additional unique interactions with active cholesterol
present only at high mol percent in comparative studies) interactions of cholesterol with the GlyR
using CX-MS. The pentameric GlyR is typically comprised of two transmembrane subunit
homologs (α and β) surrounding a central anion-selective pore arranged with a 2α:3β subunit
stoichiometry.120 Each subunit consists of a large ECD followed by four transmembrane segments
(denoted M1-M4) and an extracellular tail.125 The ligand-binding site is located at the interface
between neighboring subunits in its ECD, with aromatic residues lining the binding pocket. 216
Upon binding of the neurotransmitter glycine, GlyR transitions to a metastable open state
conformation, characteristically hyperpolarizing the post-synaptic neuron through chloride influx,
and then a long-lived non-conducting desensitized state that more tightly binds glycine. 217 The
intracellular domain consisting of loop-like structures (M1-M2 and large M3-M4 loops) has roles
in receptor trafficking and localization, and the M3-M4 loop contains a site of phosphorylation.
However the structure of this large M3-M4 loop is poorly refined in studies of pLGICs, as it is
typically excised in structural studies due to its expected flexibility. This region contains the
greatest sequence diversity among pLGICs and has not been resolved in any pLGIC
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structure,96,218,219 highlighting the importance of the development of methods that can provide
information regarding the structure of the M3-M4 loop. The C-terminal tail after M4 is also poorly
resolved in current structures. In addition, given that the structure and function of pLGICs is
modulated by lipid composition (as described above), it is imperative to develop new
complementary techniques that provide investigators with the tools to examine membrane protein
structures in native-like reconstituted membranes in the absence of detergents. CX-MS studies can
provide some of this complementary information.
Elucidating the lipid accessible regions of pLGICs are essential as modulatory anesthetics
and bioactive lipids partition within the bilayer and their effects may be mediated through the lipidprotein interface.143,144 Here, we analyzed cholesterol-human α1 GlyR interactions in the resting
state of the receptor using photocrosslinking coupled with multidimensional MS. Advancements
in MS technologies have improved the sensitivity and accuracy of detection in CX-MS
experiments, increasing the number of low-intensity crosslinked peptides identified and subjected
to tandem MS analysis.185 Current tandem mass spectrometers have the sensitivity and mass
accuracy for the unambiguous identification of crosslinked species and through peptide
fragmentation, allowing the identification of specific amino acid residue(s) involved in
crosslinking.183,184
Given the differential activities of cholesterol at low and high mol percent, azi-cholesterol,
a photoactivatable cholesterol analog, was crosslinked to wild-type human homomeric α1 GlyR at
conditions that probe interactions when cholesterol has negligible chemical activity (<25 mol
percent natural cholesterol in membrane) and when cholesterol is more chemically active (>40 mol
percent natural cholesterol in membrane). 42,220 Only at concentrations above this approximate
threshold does one observe the emergence of free “liquid” cholesterol that is chemically active.220
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This threshold correlates with the approximate concentration of cholesterol (~35 mol percent)
required for functional nAChR.86 Therefore, it is speculated that in conditions where cholesterol
has negligible chemical activity (<<33 mol percent), cholesterol would not specifically interact
with potential cholesterol-binding sites in GlyR, as chemically inactive cholesterol is postulated to
be sequestered among phospholipids and microdomains. Rather, identified crosslinks are
hypothesized to result from random diffusional encounters of cholesterol and protein. Conversely,
in chemically active cholesterol conditions (>>33 mol percent), the free “liquid” cholesterol is
chemically active (it is postulated that at elevated concentrations, cholesterol’s affinity for lipid is
exceeded) and is available to additionally interact specifically with GlyR, such that identified
crosslinks are a result of specific and non-specific interactions with cholesterol. This study shows
that MS can sensitively identify covalent sites of lipid-protein interactions, as picomoles of
purified protein are sufficient to allow identification of dozens of sites of crosslinking in each
experiment. These studies directly identify lipid-protein interactions and can aid in the refinement
of GlyR structural models derived from crystallographic and cryo-electron microscopic studies,
particularly in identifying cholesterol interactions with GlyR in reconstituted vesicles.

2.3

2.3.1

Materials and Methods

Purification of GlyR from Sf9 insect cells into mixed detergent micelles
Purified GlyR in mixed detergent/lipid micelles were isolated as previously described. 121

Briefly, WT human α1 GlyR was overexpressed in a baculovirus infected Sf9 insect cells. Three
days post-infection Sf9 insect cells were gently pelleted, washed with 1 phosphate buffered saline
(PBS) pH 7.4, and resuspended in a hypotonic solution (5 mM Tris pH 8.0, 5 mM
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ethylenediaminetetraacetic acid (EDTA), 5 mM ethylene glycol tetraacetic acid (EGTA), 10 mM
dithiothreitol (DTT)). An anti-proteolytic cocktail (1.6 µunits/mL aprotinin, 100 µM
phenylmethanesulfonyl fluoride (PMSF), 1 mM benzamidine, 100 µM benzethonium chloride)
was added to reduce protein degradation immediately preceding lysis. Cells were lysed by
sonication followed by centrifugation (387,000 x g for 30 min) to isolate cell membranes
containing GlyR. Cell membranes were washed with a resuspension buffer (hypotonic solution,
300 µM NaCl) followed by centrifugation again to remove peripheral membrane proteins. The
protein pellet was solubilized in 10:1 digitonin:deoxycholate buffer (12 mM mixed lipids (9:1 plant
extract (95% phosphatidycholine purity, Avanti): egg extract (60% phosphatidycholine purity,
Avanti) at 15 mg/mL, stored as suspended vesicles), 0.10 % deoxycholate, 1.0 % digitonin, 25 mM
potassium phosphate monobasic, 79 mM potassium phosphate dibasic, 1 M KCl, 5 mM EDTA, 5
mM EGTA, 10 mM DTT, anti-proteolytic cocktail) overnight, and solubilized micelles were
isolated after centrifugation (387,000 x g for 1 hr). GlyR/lipid/detergent micelles were affinity
purified on 2-aminostrychnine agarose and eluted competitively with the addition of excess
glycine (2 M) to the solubilization buffer.

2.3.2

Reconstitution of GlyR into lipid vesicles at defined concentrations of cholesterol,
incorporating azi-cholesterol
GlyR vesicle reconstitution was completed as previously described 124 with the following

modifications to the lipid composition. All steps were conducted in the dark and at 5˚C unless
noted. Mixed lipids (9:1 plant extract (95% phosphatidycholine purity): egg extract (60%
phosphatidycholine purity) at 15 mg/mL, stored as suspended vesicles) were added to purified
GlyR/lipid/detergent micelles to yield a final concentration of 1.5 mg/mL. Cholesterol (15.07 mM
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in methanol) was included to yield >40 mol percent and <25 mol percent for defined conditions.
Azi-cholesterol was kept at constant concentrations in both conditions at 6 µM. As previously
described, samples were added to dialysis cassette (3500 MW cutoff, Thermo) for dialysis against
excess potassium phosphate buffer (6.25 mM, pH 7.4). The final reconstituted protein pellet was
dissolved in potassium phosphate buffer (25 mM, pH 7.4). GlyR concentrations were quantitated
using a modified Lowry assay.221

2.3.3

Photo-crosslinking of Azi-cholesterol to GlyR and separation of crosslinked GlyR
Reconstituted GlyR vesicles were placed into quartz cuvettes on ice to maintain

temperature. Cuvettes were exposed to a 420 W Hg Arc lamp (Newport, Model 97435-1000-1,
260-320 nm) for 4 sessions of 5 minutes at 7 cm, with 5 minute periods of no exposure in between
each UV exposure session to prevent sample warming. SDS-PAGE (11 % resolving, 5 % stacking)
separated the crosslinked oligomeric and monomeric GlyR from lipids, with gel plugs excised
between migration distances of 250 kDa and 37 kDa, encompassing the mass of oligomeric and
monomeric forms of GlyR.

2.3.4 In-gel Trypsin digestion of crosslinked GlyR
Gel plugs were washed with 50:50 absolute methanol: 50 mM ammonium bicarbonate
twice for 40 min with gentle agitation (VWR Thermal Shake Touch, 900 rpm). Gel plugs were
dehydrated by adding 500 L acetonitrile. Once gel plugs turned whitish, acetonitrile was removed
and gel plugs were dried in an Eppendorf 5301 Vacufuge Concentrator for approximately 15
minutes. Trypsin solution (10 L at 20 g/mL in 50 mM ammonium bicarbonate) was added to
gel plugs and incubated on ice for 15 minutes, then incubated overnight at 37˚C with gentle
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agitation (VWR Thermal Shake Touch, 900 rpm). Digested peptides extracted into supernatant and
transferred to VWR non-stick microcentrifuge tubes. Tryptic fragments were further extracted by
incubating gel plugs twice for 30 minutes in 300 L of 0.1 % formic acid in 50:50 acetonitrile:H2O.
The supernatant was collected and combined with initial supernatant. Tryptic extract solution was
dried in an Eppendorf 5301 Vacufuge Concentrator.

2.3.5

Mass fingerprinting of crosslinked cholesterol to GlyR
50:50 Acetonitrile: H2O with 0.1 % Formic Acid (50 L) was added to tubes containing

dried tryptic extracts. ESI-Q-TOF-MS measurements were taken using an Agilent 6530 Q-TOFMS with an Agilent HPLC-Chip II G4240-62006 ProtID-Chip-150, comprised of a 40 nL
enrichment column and a 75 µm x 150 mm separation column packed with Zorbax 300SB-C18 5
µm material. The mass spectrometer was run on positive ion mode using internal standards
(1221.9906 and 299.2944) for calibration, supplied by Agilent. Mobile phase compositions used
were Solvent A (95 % H2O, 5 % ACN, 0.1 % Formic acid) and Solvent B (95 % ACN, 5 % H 2O,
0.1 % Formic acid) The nanoflow elution gradient was developed as follows at 0.50 µl/min of
Solvent A (minute: percent A): 0.00: 95 %, 4.00: 10 %, 6.00: 70 %, 9.00: 50 %, 11.50: 95 %, 13.00:
95 %. Data were processed using Agilent Qualitative Analysis Software 6.0. Cholesterol
crosslinked peptides within a 10 ppm accuracy window were identified, accounting for possible
peptide modifications (oxidation, acrylamidation).
For MS-MS studies, crosslinked samples were run again on the Agilent 6530 Q-TOF-MS,
targeting the specific m/z ratio, charge, and retention time of the crosslinked peptides identified in
MS analysis. CID was used for MS-MS fragmentation following a linear increase in collision
energy by m/z using the equation: y=3.7x+2.5. CID was performed at + 0.2 min from initial MS
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scan retention time of each crosslinked precursor ion identified. Data were processed using Agilent
Qualitative Analysis Software 6.0 in conjunction with ProteinProspector v5.14.3 available through
the University of California, San Francisco.

2.4 Results and Discussion

2.4.1 Cholesterol crosslinking to resting state GlyR at reduced cholesterol composition
As noted previously, cholesterol is expected to exhibit very different chemical activity as
a function of its concentration in reconstituted membranes, so comparative crosslinking studies
conducted at low and high cholesterol composition can be used to potentially map non-specific
and specific sites of protein-cholesterol interactions, respectively. Functional GlyRs were purified
from baculovirus infected Sf9 insect cells121 and reconstituted into vesicles under conditions that
have been shown to retain complete GlyR activity in outside-out orientations124 at selected lipid
composition containing constant levels of mixed plant/egg phosphatidylcholine (12 mM) and
photoactivatable azi-cholesterol (6 µM, Figure 8).
For comparative studies, the only variable was the cholesterol content in the vesicles,
which was <25 or >40 mol percent, well below or well above the published typical threshold limits

Figure 8. Chemical structure of photoactivatable azi-cholesterol. Chemical structure of cholesterol crosslinker
analog, with the reactive site highlighted in blue.

38

for cholesterol activity,42,220 respectively. The lipid composition in reconstituted vesicles was
chosen to reflect the generic lipid compositions (i.e., saturated and unsaturated acyl chains with
various headgroups) found in the cell lines used in activity assays (HEK and insect cells), dynamic
neuronal membranes56 and the studies examining cholesterol activity (described previously). 86,40
At <25 mol percent, cholesterol is expected to exhibit negligible chemical activity (sequestered in
microdomains) and identified crosslinks to GlyR are ascribed to random diffusional encounters,
and are expected to map the lipid accessible surface of the receptor. At >40 mol percent, cholesterol
is expected to have much greater chemical activity and identified crosslinking will be due to
specific interactions of the active cholesterol as well as non-specific random diffusional
encounters. In comparing the two studies (low and high cholesterol), crosslinking unique to the
>40 mol percent conditions are expected to be the specific cholesterol binding sites in GlyR, or
changes in lipid accessibility of GlyR due to structural changes as a function of increased
cholesterol concentration.

39

Table 1. Cholesterol crosslinking at reduced cholesterol composition. Identified mass-shifted precursor ions
crosslinked with cholesterol (within 10 ppm error, identified in at least 2 of 3 trials) at <25 mol percent
cholesterol conditions shown in left column. Sites of covalent modification identified upon analyses of product
ions upon CID fragmentation are bolded and underlined; spaces separating amino acids represent single point
amino acid crosslinking sites in succession. *Modifications of the precursor ion, including crosslinked
cholesterol. Precursor ions identified with different combinations of modifications are shown for each precursor
ion. Parenthesized numbers following “Azi” represent the number of crosslinked cholesterol(s) within the massshifted peptide.
Amino Acid Sequence

Structural
Location

60VNIFLR65
60VNIFLRQQWNDPR72

191

EEKDL RYCT K200

Pre-M1
ECD

194DLRYCTK200
310

QHKELLR316
313ELLRFRR319
321

RRH H K325

323

HHKEDEAGEGR333
326EDEAGEGRFNFSAYGMG
PACLQAKDGISVK355
334FNFSAYGMPACLQAK349
372SPEEMRK378

378KLFIQ

M3-M4
Loop

Modifications*

Azi
Azi (3)
Azi (4)
Azi, Acryl (2)
Azi (2), Acryl
Azi (2)
Azi (3)
Azi
Azi, Acryl
Azi (4)
Azi
Azi
Azi, Ox (2)
Azi (2), Acryl
Azi, Acryl, Ox
Azi (3), Acryl

M3-M4
Loop/M4

R383
M4

384

AKKIDK389
386KID KISR 392

Azi
Azi, Acryl
Azi, Ox
Azi (2), Ox
Azi
Azi, Acryl
Azi (3)
Azi (2), Acryl
Azi (4)

To identify lipid accessible surface of GlyR in its resting state that interacts with
cholesterol in a non-specific manner, the total cholesterol was limited to <25 mol percent where it
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is expected to exhibit negligible chemical activity.42,220 After photoactivation, GlyR containing
vesicles were subjected to SDS-PAGE and GlyR containing bands were excised, trypsinized, and
subsequently extracted peptides were analyzed by tandem MS (allowing up to 2 missed tryptic
cleavages, as photocrosslinking at Arg or Lys sites might result in reduced trypsinolysis). For all
studies, duplicate MS runs were conducted on samples from purified GlyR from 3 independent
infections/preparations, and mass shifted peptides are reported with an n of > 2. Initial MS analysis
identified precursor mass ions consistent with lipid crosslinking (cholesterol m/z shift, +386.3549
amu) using a 10 ppm cutoff (Table 1, left column).
Crosslinking analysis was conducted on data sets of each of the 3 trials with peptide
identified sequence coverage of GlyR up to 60 percent. Crosslinking analysis was not limited to a
single cholesterol crosslinking event, but allowed up to 4 cholesterol crosslinks per tryptic peptide,
as cholesterol is distributed in both leaflets of the lipid bilayer having the potential to interact at
multiple sites within a single tryptic peptide (Table 1, right column, number following “Azi”
modification), as well as “piggybacking” (cholesterol crosslinking to a GlyR bound cholesterol).
The identified precursor ions assigned to mass-shifted peptides containing cholesterol
were subjected to targeted CID, and product ions were analyzed to refine the site of crosslinking
within the mass-shifted peptide and confirm initial assignments (Table 1, bolded and underlined
amino acid(s) within each peptide). CID fragmentation typically produces b and y product ions of
the precursor mass ion. Through comparison of product ions (b, y, and occasionally a ions)
containing mass shifts due to attached cholesterol to those that do not, the site of attachment can
be refined, typically to a single amino acid site. Given that tryptic peptides could be modified at
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Figure 9. Representative CID-induced fragmentation of crosslinked precursor ion. The identified product ion
fragments (1-10), including those mass shifted (+ Azi), are highlighted.

more than a single site (for example, if two different amino acids on a given peptide are modified,
these isobaric precursor ions would provide product ions after CID that obscure assignment), MSMS spectra are strictly matched by retention time to their precursor ion. Given that in-line liquid
chromatography can potentially separate isobaric peptides via differential chemical properties,
each correlated (with respect to retention time) precursor/product pair is capable of yielding a
refined crosslinking site(s) even when present at multiple sites (sites of crosslinking within isobaric
tryptic fragments are bolded and underlined in Table 1). By individually analyzing each product
ion fragmentation spectrum at a given retention time, isobars may be unequivocally resolved in
MS-MS studies. Only precursor ions assigned to cholesterol crosslinked peptides (> tetrapeptides)
identified having overlapping sequence coverage in > 2 of 3 trials were mapped. CID
fragmentation within the retention time window (+/- 0.2 minutes) produces product ion
fragmentation spectra (2-12 spectra) of each cholesterol crosslinked peptide assigned precursor
ion were individually analyzed to identify the site of covalent attachment in its respective precursor
ion. Only product ion spectra with > 2 assigned product ions and > 2 cholesterol mass shifted
product ions were considered, with product ion spectra typically assigning up 12 cholesterol mass
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shifted ions. A representative product ion fragmentation pattern detailing the identification of
site(s) of covalent modification is shown in Figure 9.
Sites of cholesterol crosslinking following targeted MS-MS refinement were mapped to
onto a model of α1 GlyR for visualization (Figure 10A and C), however many sites of crosslinking
occur in the M3-M4 intracellular loop and the C-terminal tail of the receptor, regions that are not
resolved in any pLGIC homologs and are thus missing from the homology-based model (these
regions are discussed at greater length below and highlight the utility of CX-MS based approach
as a complement to other biophysical methods). Refinement identified single amino acid
crosslinking sites in succession as well as individual sites, with nearly all cholesterol crosslinks
refined to single amino acids, and the largest identified refined site to be a tripeptide. The refined
crosslinking sites at reduced cholesterol composition were identified in the large ECD preceding
M1 (preceding residue 220), the M3-M4 loop (residues 309-378), and transmembrane helix M4
(residues 379-410) of the GlyR resting state and are shown in Table 1 and Figure 10A and C.
Within the pre-M1 ECD, crosslinking was found in regions nearing the lipid bilayer either in beta
sheets or loops. Within the M3-M4 loop, crosslinking was identified mainly in regions nearing
either M3 or M4 transmembrane helices. Crosslinking within M4 was identified near the
cytoplasmic M3-M4 loop.
Cholesterol crosslinking sites unique to reduced cholesterol composition were observed
(Figure 10A, light green) when compared to elevated cholesterol composition. Overall, the
findings suggest the non-specific cholesterol:GlyR interactions to be mainly within
extra/intracellular domains nearing or buried within the lipid bilayer and the M4 transmembrane
helix, with these areas of GlyR expecting to have the most accessibility with the lipid interface
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Figure 10. GlyR-cholesterol interactions as a function of cholesterol concentration. Azi-cholesterol crosslinking at
(A) reduced and (B) elevated cholesterol conditions mapped to a single α1 subunit of zebrafish GlyR (PDB #3JAD)
using PyMOL v1.8.100 Areas corresponding to the bilayer are shown in gray (~15Å interfacial regions) and light
gray (~30 Å hydrophobic acyl chain region). (A). Sites of crosslinking (bolded and underlined amino acids in Table
1 and 2, respectively) uniquely identified at either low or high cholesterol levels are light green and those observed
under both conditions are dark green. Beads represent regions not resolved in the zebrafish structure (M3-M4 loop
and C-terminal tail) with crosslinks arbitrarily placed in close proximity to the lipid bilayer. Bolded beads represent
refined sites of attachment. Space-filling GlyR pentamer (with one single subunit shown as ribbon diagram) with
sites of crosslinking highlighted in green for <25 mol percent cholesterol (C) and >40 mol percent cholesterol (D).
Unresolved regions of the receptor are not shown in panels C and D.
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given the pentameric structure, highlighting the lipid accessible regions of GlyR in its resting state
when cholesterol exhibits negligible activity.
2.4.2 Cholesterol crosslinking to resting state GlyR at elevated cholesterol composition
Comparative studies and analysis analogous to those conducted with reconstituted GlyR in
its resting state at reduced cholesterol composition were similarly conducted at elevated
cholesterol composition of >40 mol percent. As before, GlyRs were purified from baculovirus
infected insect cells (duplicate MS studies of 3 independent infections) and reconstituted into
vesicles with total cholesterol enriched to >40 mol percent, but invariant levels of photoactivatable
azi-cholesterol (6 µM). At >40 mol percent, cholesterol is expected to exhibit significantly greater
Table 2. Cholesterol crosslinking at elevated cholesterol composition. Identified precursor ion crosslinked peptides
at >40 percent cholesterol with conditions as described in Table 1.

Structural
Location

Amino Acid Sequence
17

LMG RTSGYDAR27

28IR
197

P NFK33

YCTKHYNTGK206
TCIEAR213

197YCTKHYNTGKF
272ASLPKVSYVK281

321RRHH

K325

323HHKEDEAGEGR333
372SPEE

M R377
372SPEEMRK378
372SPEEMRKLIFQR383
378KLFIQRAK385
384AK

K IDK389

387IDKISRIGFPMAFLIFNMFYWIIYK411
415REDVHNQ421
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Modifications

Azi
Azi, Acryl
Pre-M1
Azi (2), Acryl
ECD
Azi, Ox
Azi (2), Acryl (3), Ox
Azi
M2-M3
Azi, Acryl
Loop
Azi (2), Acryl (2)
Azi
Azi, Ox
M3-M4
Azi (2)
Loop
Azi, Acryl, Ox
Azi, Ox
Azi, Acryl
M3-M4
Loop/M4
Azi (3), Ox
Azi, Acryl
Azi (4), Acryl
M4
Azi
Azi, Acryl (3)
Azi (4), Acryl, Ox
C-terminal Azi
tail
Azi (2), Ox

chemical activity,42,220 and specific interactions, as well as non-specific interactions (observed in
trials conducted at <25 mol percent), are expected to be observed. Alternatively, different
crosslinking sites might also be identified if higher levels of cholesterol stabilize the apo-GlyR in
a different conformation (discussed below), thus altering the lipid accessibility profile of apoGlyR. After photoactivation, GlyR was similarly subjected to SDS-PAGE and the excised GlyR
bands were trypsinized and extracted peptides were analyzed by MS-MS.
As before, MS analyses identified precursor ions corresponding to trypsinized peptides
mass shifted consistent with covalent modification with cholesterol using a 10 ppm cutoff (Table
2, an expanded Table is provided in Supplemental Material). Mass shifted precursor ions were
targeted for CID and product ions analyzed to further refine the site(s) of crosslinking. Targeted
MS-MS analysis identified product ion fragments including those containing cholesterol
crosslinks, allowing for the identification of crosslinking to single amino acids (Table 2) and these
were mapped onto a model of α1 GlyR (Figure 10B and D). The refined cholesterol crosslinking
sites were found in the large ECD preceding M1, the M2-M3 loop, the M3-M4 loop,
transmembrane helix M4, and the extracellular C-terminal tail (Table 2 and Figure 10B and D).
Within the pre-M1 ECD, crosslinking was identified in regions of beta sheets and loops. Within
the M3-M4 loop, crosslinking was identified in regions near both M3 and M4 transmembrane
helices, primarily M3. At elevated cholesterol concentrations of >40 mol percent, crosslinking
emerged in the M2-M3 loop and post M4 C-terminal tail compared to cholesterol crosslinking in
reduced cholesterol conditions (<25 mol percent). Cholesterol crosslinking sites unique to elevated
cholesterol lipid composition were observed (Figure 10B, light green) when compared to reduced
cholesterol lipid composition. Unique crosslinking sites may be due to specific cholesterol:GlyR
interaction sites in active cholesterol conditions, and these regions were identified in the pre-M1
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ECD in beta sheets and unstructured loops, the M2-M3 loop, regions of the M3-M4 loop, M4, and
the post M4 C-terminal tail. Taken together, elevated cholesterol studies revealed not only
redundant crosslinking observed in low cholesterol studies, but additional unique crosslinking
unique to studies conducted at elevated cholesterol content. Emergence of unique crosslinking to
elevated cholesterol conditions, but only partial redundancy as compared to reduced cholesterol
conditions suggests that subtle structural conformational changes occur as a function of cholesterol
concentration (discussed at more length below).
This CX-MS study highlights the power of MS to sensitively and directly identify the
cholesterol:GlyR sites of interaction in reconstituted bilayers with minute quantities of protein.
These photocrosslinking studies directly identify covalent linkages between cholesterol and GlyR

Figure 11. Comparison of predicted and experimentally determined sites of GlyR-cholesterol interaction. CRAC
(red) and CARC (dark pink) motifs and experimentally determined crosslink sites (green) under reduced (A) or
elevated (B) cholesterol composition are mapped to a single α1 subunit of zebrafish GlyR.100 Overlap between
predicted and experimental sites are shown in yellow (see arrows). No CARC or CRAC motifs are found in the
M3-M4 loop and C-terminal tail (not shown).
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as a function of cholesterol concentration. An assumption in the study is the functional and
chemical equivalence of azi-cholesterol and cholesterol, as validated in other published studies
using this crosslinker.86,222–224 Given their nearly equivalent structure, it is reasonable that azicholesterol and cholesterol interact with surrounding lipid and protein in a similar manner, and that
these two lipids share identical chemical activities that vary as a function of their aggregate
concentration. All studies were conducted at room temperature, consistent with conditions used in
determining cholesterol activity as a function of its concentration,40 as well as the temperature
typically used in whole cell patch clamping conditions used to correlate structure and function.
However, it should be noted that these studies were conducted at non-physiological temperatures,
and this may affect some of the observed interactions.
Elucidating the lipid-protein interface of ion channels is essential as it is a major site for
interactions of general anesthetics with pLGICs,225,226 synthetic neurosteroids of homomeric ɑ1
GlyR,227 and tetrahydrocannabinol with GlyR.111 All of these lipophilic compounds partition
within the bilayer and bind and modulate pLGIC activity,85,86 but high resolution structural
determination of membrane proteins typically require the presence of detergents and disruption of
the bilayer. Herein we show the capability of CX-MS to directly interrogate protein-lipid
interactions and define dozens of sites of cholesterol’s interactions with apo-GlyR in reconstituted
vesicles of defined lipid composition. Thus, this complementary analytical tool is shown to
sensitively map the lipid-protein interface as a function of lipid composition, allowing us to better
map the lipid interactome with membrane proteins. In addition, some of the sites of these
interactions are located in other poorly resolved regions of current models of pLGICs.
Amino acid consensus motifs predictive of cholesterol binding have been identified where
CRAC motifs have the sequence (L/V)-(X1-5)-(Y)-(X1-5)-(R/K) and inverted CRAC (CARC)
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motifs have the sequence (R/K)-(X1-5)-(Y/F)-(X1-5)-(L/V) where X is any amino acid.17 CRAC and
CARC motifs were mapped to a single subunit cryo-EM zebrafish α1 GlyR100 and compared with
the crosslinking data (Figure 11). Cholesterol crosslinked regions of GlyR coincided to CARC
motifs at locations within the ECD preceding and at the beginning of M1 and within M4. However,
many of the binding sites observed at reduced and elevated cholesterol composition were not in
the predicted regions. Conversely, some of the predicted binding sites were not observed
experimentally. Taken together, this suggests that although the predictive CRAC/CARC motifs
have utility, more data is necessary to ensure the motifs are more selective to accurately identify
sites of cholesterol interactions. Investigators continue to computationally model specific sites of
interaction of cholesterol with membrane proteins given the physiological significance of these
interactions.224,228
Of note, many of the regions observed in our crosslinking data are in the large intracellular
M3-M4 loop and the post-M4 C-terminal tail, regions of the receptor that are not resolved in any
crystal or cryo-EM structures of pLGICs.75,218 In particular, crosslinking within the M3-M4 loop
was often observed to charged residues of this large intracellular loop, predominately arginine,
lysine, histidine, and glutamate. Significantly, arginine and lysine are identified in CARC and
CRAC recognition sites for cholesterol binding. Evidence of lipid-accessible residues within
regions whose structure is unresolved by other biophysical methods highlights the potential of CXMS to complement other high-resolution biophysical studies and provide a wealth of unique data.
Cholesterol crosslinks in both the M3-M4 loop and post-M4 C-terminal tail suggest that these
regions are in close proximity with the membrane surface. Additionally, these events may be due
to the fluidity of the bilayer and/or protein dynamics allowing GlyR to sample different depths
within the bilayer, bringing parts of the ECD in close proximity to the membrane surface. A striking
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example of conformational flexibility of ion channels is evidenced in recent cryo-EM studies of
NMDA receptors,229 where dramatic movements of the large ECD of these receptors were
observed in a single, antagonist bound state. This large allosteric complex exhibited multiple
conformations within a single allosteric state, with regions in the ECD appearing to be intimately
associated with the bilayer. Site-directed spin-labeling studies have also large conformational
exchanges to be present in regions of membrane proteins in native bilayers that are not observed
in well-ordered crystallographic studies. 230 The sensitivity of CX-MS to capture conformational
heterogeneity via covalent crosslinking is yet another tool that may assist in identifying dynamic
intimate associations between regions of membrane proteins. One potential limitation to CX-MS
is the inability to easily determine the relative frequency of these events, as quantification of the
relative abundance of crosslinks is difficult, and will be further discussed below.
The M4 region of pLGICs face the periphery of the receptor and have been shown to be
lipid accessible,195 so it was anticipated that CX-MS studies would identify amino acids within
this region under low and high cholesterol conditions. Multiple crosslinking sites at the
intracellular end of M4 were reproducibly identified in both cholesterol conditions, with unique
crosslinking of R383 at low conditions and K386 at high conditions, suggesting a subtle rotation of
M4 as a function of cholesterol content. Thus, our results are consistent with nAChR studies231
that posits conformationally distinct resting states under low and elevated cholesterol content. As
expected, M4 sites were identified in CX-MS studies, however, cholesterol crosslinking in both
reduced and elevated cholesterol composition were also identified in other regions of the receptor,
including the ECD preceding M1 and the M3-M4 loop (Figure 10). Given the high solubility of
cholesterol in DOPC bilayers (67 mol%),232 its strong partition coefficient for octanol over water
(logPoct/wat is 7.39) and its essential insolubility in water (~2.6 x 10 -5 mg/ml),233 it is assumed that
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all cholesterol is sequestered within the bilayer. In addition to crosslinks within M4, covalently
modified sites were reproducibly identified in regions expected to be far from the bilayer (e.g.,
60VNIFLRQQWNDPR72

and

17LMGRTSGYDARIRPNFK33

(residues in bold identify sites of

covalent modifications within the mass-shifted tryptic peptide) in reduced and elevated cholesterol
composition, respectively). While it is difficult to accommodate bilayer cholesterol interacting
directly with some of the regions that appear to be far away from the membrane in the ECD (Figure
9), the reproducibility of distinct binding sites as a function of cholesterol concentration is
observed in our studies and this reproducibility is considered evidence that these are not random
events due to misfolded protein and/or cholesterol in the aqueous phase. Rather, these sites, that
also contain CARC and CRAC motifs, are postulated as being a hydrophobic cavity that may
sequester cholesterol introduced in the mixed micelles during purification. Isoflurane and
ketamine, general anesthetics, bind to homologous regions of the ECD of nAChR234 and GLIC,146
consistent with the presence of conserved hydrophobic binding pockets in the ECD of pLGICs
located distantly from the bilayer.
Under elevated cholesterol conditions (>40 mol percent), cholesterol crosslinking
locations were refined to many of the same regions as observed in comparative studies at reduced
cholesterol levels, but additionally included unique sites in the ECD, the M2-M3 loop, and the
post-M4 C-terminal tail of the receptor. As described previously, at membrane concentrations
below ~33 mol percent, cholesterol exhibits negligible chemical activity due to its affinity to form
complexes with phospholipids).42,220 We propose that cholesterol crosslinks identified uniquely at
high cholesterol levels may be due to specific cholesterol binding sites in the receptor or changes
in lipid accessibility if the receptor adopts a different conformation at elevated cholesterol levels.
Within the ECD preceding M1, extensive labeling of specific cholesterol crosslinked residues were
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refined to

25DARIRPNFK33

and

202YNTGKFTCIEAR213,

the latter of which precedes the M1

transmembrane helix and might be expected to be located near the interfacial region of the lipid
headgroups. Residues 272 ASLPKVSYV280 of the M2-M3 loop were specifically crosslinked only
at elevated cholesterol conditions, a region of the protein that is flanked by a neighboring subunit,
suggesting non-annular interactions. This region is believed to be critical in allosterically linking
ligand binding events with channel gating. With the post-M4 C-terminal tail, a region not resolved
in any pLGICs,218 extensive labeling was only observed at elevated [cholesterol] at residues
415REDVHNQ421 ,

suggesting an intimate association with the bilayer surface at these levels.

Cholesterol crosslinks identified under conditions where cholesterol is expected to have
low chemical activity are assumed to identify non-specific sites of lipid-accessibility to GlyR. As
described in the previous paragraph, some subtle differences were observed in the labeling of M4
as a function of cholesterol concentration. Unique crosslinking sites at lower cholesterol
composition were also refined to the large ECD preceding M1 and the M3 -M4 loop. Within the
ECD preceding M1, exclusive labeling was refined to
191EEKDLRYCTK200,

60 VNIFLRQQWNDPR72

and

the former being a region flanked by a neighboring subunit with some lipid

accessibility while the later is directly exposed at the protein:lipid interface of GlyR. Within the
intracellular M3-M4 loop, a poorly resolved region in structural determinations of all pLGICs to
date, cholesterol crosslinking is uniquely observed to

349KDGISVK355,

suggesting this region is

intimately associated with the membrane surface only at lower cholesterol concentrations. For
visualization, unique crosslinking sites observed in both reduced and elevated cholesterol
compositions were mapped to a single subunit of a single subunit cryo-EM zebrafish α1 GlyR100
(Figure 10A and B, light green regions). Given that unique crosslinking locations were also
observed in the reduced cholesterol composition (<25 mol percent) not observed in the elevated
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cholesterol composition (>40 mol percent), this suggests that GlyR adopts subtly different
conformations at low and high cholesterol levels. This is consistent with observations that nAChR
adopts an uncoupled conformation in the absence of cholesterol and anionic lipids that is distinct
from the resting and desensitized states.231
A limitation of the current studies is that the relative abundance of the crosslinking events
could not be determined as peak intensities in MS studies reflect the abundance of the mass ion,
reporting on the relative ionization of the species, not its concentration. Accurate quantification
would allow discrimination of high probability events from low probability events, further refining
the specific interactions of cholesterol with GlyR. This is a common problem in MS-based
discovery studies that confound the use of isotopically enriched standards. Future studies plan to
incorporate a laser-induced fluorescence microfluidic platform under development to sensitively
quantify derivatized peptides concurrent with MS-MS studies. Regardless, the methods described
have reproducibly identified dozens of cholesterol crosslinks as a function of cholesterol
concentration. Of note, these CX-MS studies do not require large amounts of purified receptor, as
picomoles of protein in a single SDS-PAGE gel is sufficient to identify dozens of crosslinks. In
addition, these studies are conducted in reconstituted lipid vesicles, in the absence of detergents,
and can be conducted in a state-dependent manner in the presence or absence of agonists,
antagonists, allosteric ligands with any desired lipid composition to identify changes in lipid
accessibility upon channel gating and desensitization.
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CHAPTER 3: STATE-DEPENDENT CHOLESTEROL-GLYR INTERACTIONS

3.1

Abstract
PLGIC allostery is dependent on dynamic associations with its diverse environment. The

cellular membrane’s lipid composition influences channel function with cholesterol being a key
regulator of channel activity. Human α1 GlyR was purified from baculovirus infected insect cells
and reconstituted in unilamellar vesicles at physiological cholesterol:lipid ratios with aliquots of
azi-cholesterol, a photoactivatable non-specific crosslinker. The receptor in vesicles was then
enriched in either a resting, open, or desensitized state prior to photocrosslinking. Following
photoactivation, crosslinked cholesterol-GlyR was trypsinized and sites of direct covalent
attachment to peptides were identified by targeted MS-MS. Dozens of state-dependent crosslinks
were identified and differential patterns of cholesterol-GlyR crosslinks were observed in the
extracellular region nearing the lipid bilayer, in the M4 transmembrane helix, and in the large
intracellular M3-M4 loop. Unique crosslinks in comparative studies identify changes in lipid
accessibility or modulation of hydrophobic cavities in GlyR as a function of receptor allostery.
Most notably, the outward twisting of M4 and differential crosslinking within the M3 -M4 loop
provide new insight into allosteric repositioning of GlyR. More generally, this study provides an
accurate and sensitive approach to mapping the protein-lipid interactions to discern statedependent structural movements of membrane proteins.

3.2 Introduction
Protein function is modulated by dynamic interactions with other biomolecules such as
metabolites, proteins and lipids, and the cellular membrane’s lipid composition has been
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increasingly recognized as a major contributor in membrane protein function. 235,236 The current
model of the lipid membrane suggests a non-homogenous distribution of lipids and proteins that
form microdomains, with the lipid composition modulating cellular processes at the protein-lipid
interface either directly (i.e., binding) or indirectly (altering the physiochemical properties of the
bilayer).52–54 Examples of these effects are the influence of lipid composition on the
structure/stability of the transmembrane domain of amyloid precursor protein,58 the modulation of
β2-adrenergic receptor dimer interface stabilization through cholesterol occupancy,62 the
abrogation of dimer formation of the leucine transporter from cardiolipin delipidation,63 and the
effects of cholesterol on ion channels.80,208,209 Lipids modulate agonist binding of GluCl through
occupancy of membrane-spanning intersubunit crevices, promoting an expanded, open-like
conformation that potentiates the receptor.75 The potency of GABAR is diminished by cholesterol
depletion and restored through cholesterol enrichment of neurons.79 Lipids are frequently observed
co-crystallized with membrane proteins, underlining the importance of specific protein-lipid
interactions.65 For example, cholesterol co-crystallizes with G-protein coupled receptors,68 Na+,K+
ATPase,69 and the dopamine transporter,71 and phospholipid co-crystallizes with GluCl75 and
GLIC.77
Many pharmaceuticals (anesthetics, barbiturates, benzodiazepines, cannabinoids, and
alcohol) and bioactive lipids (progesterone, sphingomyelin, and ceramide) specifically target the
pLGIC superfamily of ion channels.111,132–134 Anesthetics alter the permeability of both anionselective and cation-selective channels. However the molecular mechanism of channel modulation
remains poorly understood.135 Bioactive lipids play a more diverse role, including the regulation
of cell-surface nAChR levels,134 the inhibition of GABAR,133 and the modulation of nAChR
desensitization.140 Intriguingly, both anesthetics and bioactive lipids partition at the lipid-protein
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interface in cellular membranes,143,144 with the former being observed in crystal structures of
pLGIC structural homologues.145,146 Cannabinoids such as Δ9 -tetrahydrocannabinol potentiate
GlyR activity via interactions at the protein-lipid interface.237 Screening of GlyR for cannabinoidlike potentiating agents is an effective tool to discover novel therapeutics 111 highlighting the
importance in developing methodologies to sensitively probe protein-lipid interactions. Direct
effect of anesthetic agents and alcohol of pLGICs provide valuable models for general allosteric
modulation and to further develop anesthetic agents.238
Cholesterol and saturated lipids enrich lipid rafts forming highly ordered microdomain
complexes distinct from the surrounding disordered lipid environment, with this highly ordered
domain providing a mechanism for protein interactions and the regulation of cellular processes.239
Cholesterol in molar excess of the capacity of these complexes has high fugacity, and is regarded
as “active cholesterol”,36 as seen by an abrupt increase in sterol availability to cholesterol
oxidase,37 perfringolysin,38 and methyl-β-cyclodextrin39 emerging at concentrations above 25-35
mol percent.40,41 Excess cholesterol exhibits high chemical activity in a chemical phase distinct
from that observed under negligible chemical activity42 that may potentially drive regulatory
processes within or on the plasma membrane surface,43 either indirectly by modulating plasma
membrane physical properties or directly as a protein regulator.20 Cholesterol and anionic
phospholipids modulate nAChR allosteric transitions whereby cholesterol enrichment of
cholesterol-depleted membranes up to a given threshold (~35 mol%) enhanced receptor-mediated
ion flux from inactive channels to being able to undergo agonist-induced state transitions.82–86 This
profound regulatory effect of cholesterol also causes nAChR to adopt distinct conformations as a
function of cholesterol concentration, where in the absence of cholesterol or anionic phospholipids
adopting a conformation that has properties distinct of the resting or desensitized state in which
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the allosteric coupling between neurotransmitter binding sites and the transmembrane pore is
lost.87,88 Similarly, CX-MS studies identified differential GlyR-cholesterol crosslinking patterns at
low and high cholesterol concentrations, suggesting that GlyR adopted distinct conformations as
a function of cholesterol concentration.178
The transient nature of neuronal receptor allostery typically poses a challenge for
experimental characterization, however the approach of using photocrosslinking provides an
opportunity to probe the dynamics of receptor gating and desensitization.179,180 Photoaffinity
labeling studies identified the propofol-binding site of GLIC190 and GABAR191 as well as
cholesterol interactions with the PBR,192 nAChR,194,195 and GlyR.178 The incorporation of sensitive
MS-based approaches to sensitively identify sites of photocrosslinking has the potential to identify
allosteric dynamics of protein structure in membranes and to examine the role of lipids in receptor
allostery.178,179 Current tandem MS instruments have the mass accuracy and sensitivity to
unambiguously identify and refine crosslinked species to amino acid residue(s) within a given
peptide.178,183,184 CX-MS studies provide a valuable adjunct to crystallography and cryo-EM
studies particularly in less resolved regions of images by providing amino acid proximity and
distance constraint information useful in homology or de novo modeling.240 Data provided by
state-dependent CX-MS can supplement assays elucidating channel mechanisms of
activation/desensitization241 and allosteric coupling of domains242 by providing dynamic localized
information regarding structural changes often in unresolved regions of proteins.
Given the essential, yet poorly characterized structural effects of cholesterol modulation
of pLGICs, we examined cholesterol accessibility of GlyR at physiological levels, >40 mol%
(above its activity threshold), in a state-dependent manner. This study focuses on comparative
cholesterol-GlyR interactions, i.e. comparing differential azi-cholesterol crosslinking under
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elevated “active” cholesterol conditions of the resting, open (F207A/A288G, 30 nM
ivermectin),205 and desensitized state (10 mM glycine) using photocrosslinking coupled with
multidimensional MS. The F207A/A288G double mutant GlyR produces an ivermectin-sensitive
channel unable to desensitize.205 These studies expand upon a previous study178 that contrasted
azi-cholesterol crosslinking to the resting state of 1 GlyR under low and high cholesterol levels.
GlyR in the presence of saturating concentrations of glycine activate and stabilize channels
predominantly in a higher-affinity ligand-bound conformation, with potential sampling of other
states. F207A/A288G GlyR in the presence of nanomolar concentrations of ivermectin has been
shown to stabilize channels in a conducting conformation that does not desensitize.205 Azicholesterol, a photoactivatable cholesterol analog, was crosslinked to human homomeric α1 GlyR
(wild-type and F207A/A288G) at conditions that probe interactions when cholesterol is chemically
active (>40 mol percent natural cholesterol in membrane) in a state-dependent manner.42,220 This
study shows that photocrosslinking coupled with tandem MS can map a lipid-protein interface in
several allosteric states/conformations, depicting lipid accessibility during transient structural
changes. Direct cholesterol-GlyR interactions have been identified in different allosteric
conformations that can help refine GlyR crystallographic/cryo-electron microscopic models,
principally in unresolved regions, provide insight into ion channel dynamics of gating and
desensitization.
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3.3

3.3.1

Materials and Methods

Purification of GlyR from Sf9 insect cells into mixed detergent micelles
Purified GlyR in mixed detergent/lipid micelles were isolated as previously described.121

Briefly, WT human α1 GlyR was overexpressed in a baculovirus infected Sf9 insect cells. Three
days post-infection Sf9 insect cells were gently pelleted, washed with phosphate buffered saline
(137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4), and resuspended in
a hypotonic solution (5 mM Tris pH 8.0, 5 mM EDTA, 5 mM EGTA, 10 mM DTT). An antiproteolytic cocktail (1.6 µunits/mL aprotinin, 100 µM phenylmethanesulfonyl fluoride, 1 mM
benzamidine, 100 µM benzethonium chloride) was added to reduce protein degradation
immediately preceding lysis. Cells were lysed by sonication followed by centrifugation (387,000
x g for 30 min) to isolate cell membranes containing GlyR. Cell membranes were washed with a
resuspension buffer (hypotonic solution above with 300 µM NaCl) followed by centrifugation
again to remove peripheral membrane proteins. The protein pellet was solubilized in 10:1
digitonin:deoxycholate buffer (12 mM mixed lipids (9:1 plant extract (~95% phosphatidycholine
purity, Avanti): egg extract (~60% phosphatidycholine purity, Avanti) at 1.5 mg/mL, stored as
suspended vesicles), 0.10 % deoxycholate, 1.0 % digitonin, 25 mM potassium phosphate (KPi, pH
7.4), 1 M KCl, 5 mM EDTA, 5 mM EGTA, 10 mM DTT, anti-proteolytic cocktail) overnight, and
solubilized micelles were isolated after centrifugation (387,000 x g for 1 hr). GlyR/lipid/detergent
micelles were affinity purified on 2-aminostrychnine agarose and eluted competitively with the
addition of excess glycine (2M for WT preps) or strychnine-sulfate pentahydrate (1.5 mM for
F207A/A288G preps) to the solubilization buffer.
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3.3.2 Reconstitution of GlyR into lipid vesicles incorporating azi-cholesterol
GlyR vesicle reconstitution was completed as previously described124 with the following
modifications to the lipid composition. All steps were conducted in the dark and at 5˚C unless
noted. Mixed lipids (9:1 plant extract (95% phosphatidycholine purity): egg extract (60%
phosphatidycholine purity) at 15 mg/mL, stored as suspended vesicles) were added to purified
GlyR/lipid/detergent micelles to yield a final concentration of 1.5 mg/mL. Cholesterol (15.07 mM
in methanol) with 6 µM azi-cholesterol was included to yield >40 mol percent. As previously
described, samples were added to dialysis cassette (3500 MW cutoff, Thermo) for dialysis against
excess 6.25 mM KPi buffer at pH 7.4. The final reconstituted protein pellet was dissolved in 25
mM KPi buffer at pH 7.4. GlyR concentrations were quantitated using a modified Lowry assay.221

3.3.3

Photo-crosslinking of azi-cholesterol to GlyR and separation of crosslinked GlyR
Reconstituted GlyR vesicles were placed into quartz cuvettes on ice to maintain

temperature. Photocrosslinking of azi-cholesterol to GlyR was completed as previously
described178 with the following modifications. To enrich for GlyR in the open state, 30 nM
ivermectin was added to reconstituted GlyR vesicles (F207A/A288G) immediately before UV
light exposure. To enrich for GlyR in the desensitized state, 10 mM glycine was added to
reconstituted GlyR (WT) vesicles immediately before UV light exposure. Cuvettes were exposed
to a 420 W Hg Arc lamp (Newport, Model 97435-1000-1, 260-320 nm) for 4 sessions of 5 minutes
at 7 cm, with 5 minute periods of no exposure in between each UV exposure session to prevent
sample warming. SDS-PAGE (11 % resolving, 5 % stacking) separated the crosslinked oligomeric
and monomeric GlyR from lipids, with gel plugs excised between migration distances of 250 kDa
and 37 kDa, encompassing the mass of oligomeric and monomeric forms of GlyR.
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3.3.4 In-gel Trypsin digestion of crosslinked GlyR
Gel plugs were washed with 50:50 methanol: 50 mM ammonium bicarbonate twice for
40 min with gentle agitation (VWR Thermal Shake Touch, 900 rpm). Gel plugs were dehydrated
by adding 500 L acetonitrile. Once gel plugs turned whitish, acetonitrile was removed and gel
plugs were dried in an Eppendorf 5301 Vacufuge Concentrator for approximately 15 minutes.
Trypsin solution (10 L at 20 g/mL in 50 mM ammonium bicarbonate) was added to gel plugs
and incubated on ice for 15 minutes, then incubated overnight at 37˚C with gentle agitation (VWR
Thermal Shake Touch, 900 rpm). Digested peptides extracted into supernatant and transferred to
VWR non-stick microcentrifuge tubes. Tryptic fragments were further extracted by incubating gel
plugs twice for 30 minutes in 300 L of 0.1 % formic acid in 50:50 acetonitrile:H 2O. The
supernatant was collected and combined with initial supernatant. Tryptic extract solution was dried
in an Eppendorf 5301 Vacufuge Concentrator.

3.3.5

Mass fingerprinting of crosslinked cholesterol to GlyR
50:50 Acetonitrile: H2O with 0.1 % Formic Acid (50 L) was added to tubes containing

dried tryptic extracts. ESI-Q-TOF-MS measurements were taken using an Agilent 6530 Q-TOFMS with an Agilent HPLC-Chip II G4240-62006 ProtID-Chip-150, comprised of a 40 nL
enrichment column and a 75 µm x 150 mm separation column packed with Zorbax 300SB-C18 5
µm material. The mass spectrometer was run on positive ion mode using internal standards
(1221.9906 and 299.2944) for calibration, supplied by Agilent. Mobile phase compositions used
were solvent A (95 % H2 O, 5 % ACN, 0.1 % formic acid) and solvent B (95 % ACN, 5 % H 2O,
0.1 % formic acid) The nanoflow elution gradient was developed as follows at 0.50 µl/min of
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solvent A (minute: percent A): 0.00: 95 %, 4.00: 10 %, 6.00: 70 %, 9.00: 50 %, 11.50: 95 %, 13.00:
95 %. Data were processed using Agilent Qualitative Analysis Software 6.0. Cholesterol
crosslinked peptides within a 10 ppm accuracy window were identified, accounting for possible
peptide modifications (oxidation, acrylamidation).
For MS-MS studies, crosslinked samples were run again on the Agilent 6530 Q-TOF-MS,
targeting the specific m/z ratio, charge, and retention time (RT) of the crosslinked peptides
identified in MS analysis. CID was used for MS-MS fragmentation following a linear increase in
collision energy by m/z using the equation: y=3.7x+2.5 (y= m/z, x= collision energy). CID was
performed at + 0.2 min from initial MS scan RT of each crosslinked precursor ion identified. Data
were processed using Agilent Qualitative Analysis Software 6.0 in conjunction with
ProteinProspector v5.14.3 available through the University of California, San Francisco.

3.4 Results
Our previous study178 identified apo state azi-cholesterol-1 GlyR crosslinking as a
function of cholesterol concentration where differential crosslinking patterns were observed
between cholesterol conditions of negligible chemical activity and chemically active, suggesting
two distinct structural conformations of apo-state GlyR as a function of cholesterol concentration.
The dependence of pLGIC activity on cholesterol has been long established and these studies were
consistent with FTIR studies demonstrating the uncoupling of ligand binding from pore opening
as a consequence of decreased cholesterol content.231 Given the requirement for GlyR activity on
more elevated cholesterol concentrations, all of our comparative studies of homopentameric
human 1 GlyR examining cholesterol crosslinking as a function of receptor allostery were
conducted at the higher cholesterol concentrations consistent with physiological conditions.
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In our previous studies,178 azi-cholesterol crosslinking was observed in pre-M1
extracellular domain on the outer lipid-exposed surface, the extracellular M2-M3 loop, regions of
the large intracellular M3-M4 loop, the M4 transmembrane helix, and the post-M4 c-terminal tail
(Table 2). In this study we extend these studies to examine cholesterol photocrosslinking in a statedependent manner, conducting comparative crosslinking studies on purified and reconstituted
human 1 GlyR enriched in either its resting, open or desensitized states. Ivermectin promotes
predominant stabilization of channels in a conducting conformation (open state) in F207A/A288G
a1 GlyR.205 In our hands, F207A/A288G GlyR expressed in insect cells were gated by ivermectin
in whole cell patch clamp studies and showed no evidence of desensitization (Tomcho et al.,
Table 3. Identified open state precursor/product ion crosslinked peptides at >40 percent cholesterol with conditions
as described in Table 2.

Structural
Location

Amino Acid Sequence
17

LMG RTSGYDAR27
28

IR P NFK33

Pre-M1
ECD

197

YCTKHYNTGK206
197
YCTKHYNTGKF TCIEAR213
272

ASLPKVSYVK281

321

M2-M3 Loop

RRHH K325
M3-M4 Loop

323

HHKEDEAGEGR333
372
SPEE M R377
372
SPEEMRK378
372
SPEEMRKLIFQR383
378

KLFIQRAK385

384
387

M3-M4 Loop/M4

M4

AK K IDK389

IDKISRIGFPMAFLIFNMFYWIIYK411
415

REDVHNQ421

C-terminal tail
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Modifications
Azi
Azi, Acryl
Azi (2), Acryl
Azi, Ox
Azi (2), Acryl (3), Ox
Azi
Azi, Acryl
Azi (2), Acryl (2)
Azi
Azi, Ox
Azi (2)
Azi, Acryl, Ox
Azi, Ox
Azi, Acryl
Azi (3), Ox
Azi, Acryl
Azi (4), Acryl
Azi
Azi, Acryl (3)
Azi (4), Acryl, Ox
Azi
Azi (2), Ox

manuscript in preparation), consistent with published observations. 205 Under excess ivermectin
conditions (1.5 mM) these non-desensitizing channels are expected transition between open or
resting states, and comparative CX-MS studies with apo studies should identify mass-shifted ions
unique to each study, thus allowing identification of unique cholesterol binding sites restricted to
each of these states (or exposed during structural transitions between the resting and open state).
Similarly, in order to examine cholesterol accessibility in the desensitized state of the receptor,
cholesterol interactions were examined in conditions of excess glycine enriching GlyR in a higheraffinity ligand-bound desensitized conformation. Given that the receptor is expected to exist in
resting, open, and (primarily) desensitized states, comparative studies are conducted to identify
crosslinking sites uniquely observed in the presence of excess glycine and not in our resting or
open state studies.
In this section we present evidence of crosslinks identified by LC-MS-MS in each of the
three comparative studies, but defer more detailed interpretation of these data until the following
Discussion section. In all cases, crosslinks presented were identified in at least 2 of 3 independent
sample preparations/MS analysis pairings. Identified crosslinks from independent preparations
were obtained from a single LC-MS and LC-MS-MS paired experiment. For LC-MS-MS analysis,
mass errors in precursor/product ion identification were restricted to < 10 ppm/0.1 Dalton,
respectively. Due to the presence of isobaric species (i.e., cholesterol binding at more than one
location, such as adjacent amino acids, within a given proteolytic fragment), strict pairing of the
retention times of product ions and their respective precursors allows multiple crosslinks to be
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identified from isobaric precursor ions in single trials due to their respective differential retention
times on the LC-MS-MS platform.

B

A

C loop

C-term

C loop

Loop 2

M3-M4 Loop

Loop 2

C-term

M3-M4 Loop

Figure 12. State-dependent GlyR-cholesterol interactions at active cholesterol conditions. Azicholesterol crosslinking at (A) open state and (B) desensitized state mapped to a single α1
subunit of zebrafish GlyR (PDB #3JAD) using PyMOL v1.8. 100 Areas corresponding to the
bilayer are shown in gray (~15Å interfacial regions) and light gray (~30 Å hydrophobic acyl
chain region). Sites of crosslinking in the open and desensitized (bolded and underlined amino
acids in Table 2-3, respectively) identified are shown in green. Beads represent regions not
resolved in the zebrafish structure (M3-M4 loop
65 and C-terminal tail) with crosslinks arbitrarily
placed in close proximity to the lipid bilayer. Bolded beads represent refined sites of attachment.

In studies conducted on non-desensitizing F207A/A288G GlyR, cholesterol crosslinking
was identified in the pre-M1 extracellular domain in regions distant of the membrane and closer
proximity with the ECD-TMD interface, the entire span of the large intracellular M3-M4 loop, the
lower portion of the M4 transmembrane helix, and the post-M4 C-terminal tail (Table 3), and these
sites were visualized on a single α1 subunit of zebrafish GlyR (PDB #3JAD)(Figure 12A).100
Many crosslinks were found in unresolved regions of the α1 GlyR model (the M3-M4
loop and C-terminal tail), and are depicted as colored beads. These crosslinking events suggest
that these sites are in close proximity hydrophobic core of the lipid bilayer, suggesting an intimate
association of large swaths of the heretofore unresolved M3-M4 linker with the periphery of the
hydrophobic core of the bilayer (the expected depth of the diazirine moiety on azi-cholesterol

Figure 13. Allosteric GlyR-cholesterol interactions at active cholesterol conditions. Side view of the space-filling
GlyR pentamer (with one single subunit shown as ribbon diagram, PDB #3JAD 100) with sites of crosslinking
highlighted in green for the (A) resting state178, (B) open state, and (C) desensitized at >40 mol percent cholesterol.
Unresolved regions of the receptor are not shown in panels A-C.
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(Figure 12). A profile side view of crosslinked regions (Figure 13B) displays these annular
associations, yet also exposes more buried non-annular cholesterol interactions in hydrophobic
pockets between subunits consistent with nAChR 222 and GABAAR79 studies.
In bottom-up views of the receptor (Figure 14B) crosslinking locations are localized on outer
surface of GlyR, highlighting the expected predominant annular lipid surface accessibility.
Cholesterol crosslinking only identified in open state studies, not in the apo-state is suggested to
be unique cholesterol-GlyR interactions of the open state. Cholesterol crosslinking unique to the
open state GlyR was observed in the pre-M1 extracellular domain in regions distant to (residue
numbers 3, 10, 15-16, 52-55, 58) and nearing (residue numbers 105-106, 116, 193, 197, 201) the
membrane, the large intracellular M3-M4 loop (residue numbers 227-231, 233, 237-241, 245-247,
249, 334-337, 345-348, 350-352, 356-357, 359-371, 374), the M4 transmembrane helix (residue
number 383), and the post-M4 c-terminal tail (residue number 417).

Figure 14. Allosteric GlyR-cholesterol interactions at active cholesterol conditions. Bottom-up view of the spacefilling GlyR pentamer (with one single subunit shown as ribbon diagram, PDB #3JAD100 ) with sites of crosslinking
highlighted in green for the (A) resting state178, (B) open state, and (C) desensitized at >40 mol percent cholesterol.
Unresolved regions of the receptor are not shown in panels A-C.
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In studies conducted on WT receptor in the presence of excess glycine, cholesterol
crosslinking was identified in the pre-M1 extracellular domain in regions distant of the membrane
and closer proximity with the ECD-TMD interface, three distinct regions of the large intracellular
M3-M4 loop, the lower region of the M4 transmembrane helix, and the post-M4 C-terminal tail,
mapped to a single α1 subunit of zebrafish GlyR (PDB #3JAD) (Table 4, Figure 12B).100
Table 4. Identified desensitized state precursor ion crosslinked peptides at >40 percent cholesterol with conditions
as described in Table 2.

Amino Acid Sequence
1

3

Structural Location

ARSATKPMSPSDFLDK16

SA TKPMSPSDFLDKLMGRTSGYDAR27
28

105

105

GAHFHEITTDNK116

GAHF HEITTDNKLLR119
191

194

197

IR PNFK33

Pre-M1 ECD

EEKDL RYCTK200

DLRYCTK HYNTGK206

YCTKH YNTGKFTCIEA R213

323

HHKEDEAGEGRFNFSAYGMGPACLQAK349
326
EDEAGEGRFNFSAYGMGPACLQAKDGISVK355
M3-M4 Loop
356

377

GANNSNTTNPPPAPSKSPEE MR
379

415

LFIQRAK385

M4

REDVHNQ421

C-terminal Tail
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Modifications
Azi, Acryl, Ox
Azi, Ox
Azi, Acryl (2), Ox
Azi, Ox
Azi, Acryl (2), Ox (2)
Azi (2), Acryl
Azi, Ox (2)
Azi
Azi, Acryl, Ox
Azi, Acryl, Ox (2)
Azi, Acryl
Azi, Acryl (2)
Azi, Acryl (2), Ox
Azi, Acryl (3), Ox
Azi, Acryl (3)
Azi, Acryl
Azi, Ox
Azi, Acryl
Azi (2), Acryl
Azi, Ox
Azi
Azi
Azi, Acryl
Azi, Ox
Azi (4)
Azi
Azi (2)
Azi, Ox
Azi

Crosslinking was observed in unresolved M3-M4 loop and C-terminal tail of the α1 GlyR model
(Figure 12B, M3-M4 loop and C-terminal tail, depicted as colored beads) and suggested to be
intimately associated with the lipid membrane. Examination of the accessible surface of the
pentamer, either by profile side view (Figure 13C) or viewed intracellularly facing outward (Figure
14C), show sites of crosslinking on both the outer surface, annular lipid-accessible regions of GlyR
as well as more buried non-annular regions consistent with crosslinking observed in the resting
and open state trials. Cholesterol crosslinking uniquely observed in studies in excess glycine are
proposed to be unique cholesterol-GlyR interactions of the desensitized state, and was identified
in the pre-M1 extracellular domain in regions distant to (residue numbers 4-6, 11) and nearing
(residue numbers 108-112, 119, 191-192, 194-196) the membrane, and intracellular M3-M4 loop
(residue numbers 353-355, 373).

3.5 Discussion
The differential cholesterol crosslinking patterns discerned in this study between
conditions stabilizing the resting, open, and desensitized states of GlyR shows that CX-MS can
identify unique cholesterol interactions in a state-dependent manner. This change in the pattern of
cholesterol crosslinking between functional states details structural movements between allosteric
conformations and define lipid-accessible hydrophobic regions of GlyR, as well as hydrophobic
pockets in the receptor. Currently there are structures of GlyR bound to agonist/antagonist, 100
ivermectin,100,218 and analgesic potentiators,243 as well as forthcoming cryo-EM structures.241
However, many of these structures have deletions and mutations for thermostability, are bound to
ligand, and often lack the presence of a bilayer, providing limitations in modeling function of
pLGICs. This discontinuity emphasizes the need for continued and improved methodologies to be
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able to provide additional information for each allosteric state for full-length receptors in the
presence of a lipid bilayer. State-dependent comparative CX-MS studies offer the unique capability
of complementing other high resolution methodologies to help refine dynamic changes of
membrane proteins under physiological conditions. Under physiological conditions, CX-MS can
differentiate subtle structural movements throughout the majority of the protein, including regions
absent in current structures. The synergistic utility of CX-MS with common structural techniques
(x-ray crystallography and cryo electron microscopy) can drastically enhance the allosteric
understanding of membrane proteins.
In the absence of quantification, this comparative state-dependent cholesterol-GlyR study
is unable to distinguish high frequency from low frequency crosslinks identified. Therefore, it is
assumed that crosslinking studies conducted in the presence of ivermectin (labeled as open state
crosslinking) will capture crosslinks of both resting and open state channels as well as accessibility
during state transitions as we are unable to distinguish crosslinking specific to the resting, open,
or intermediate structures. Similarly, crosslinking studies conducted in the presence of glycine
(labeled as desensitized state crosslinking) will capture crosslinks of the resting, open, and
desensitized channels as well as accessibility during state transitions as we are unable to
distinguish crosslinking specific to the resting, open, desensitized, or intermediate structures.
Unique crosslinks identified within each three conditions tested are suggested to be distinctive
cholesterol-GlyR interaction profiles and consist of up to ~58% of crosslinks identifies within each
condition.
Sites of cholesterol crosslinking determined in CX-MS studies were visualized through
mapping on the α1 GlyR strychnine-bound model.100 This model was selected to most closely
resemble the apo-state conditions tested in the previous study given the three available α1 GlyR
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models (strychnine, glycine, and glycine/ivermectin bound).100 To maintain consistency, all
crosslinks of this CX-MS study are mapped on this single static model to enhance identification
of regions exhibiting changes in lipid accessibility, thereby identifying movements of the receptor
underlying gating and desensitization. Consequently the mapping shown for each allosteric state
(open and desensitized) may not accurately represent structural-based crosslink localization
identified for each state, however gives an approximate depiction of the crosslinked regions. Exact
structural changes based upon state-dependent cholesterol crosslinking patterns mapped on the
model are suggested to be a result of either cholesterol or protein relocation. Changes in
cholesterol’s interaction location based upon lipid relocation are suggested to be from
repositioning within hydrophobic pockets or regions of lipid accessibility. Changes in cholesterol’s
interaction location based upon GlyR repositioning causes mapped crosslinked site(s) to differ
from state to state, where the directional movement of cholesterol location is the opposite of GlyR
actual repositioning.
Shifts of crosslinking patterns within M4 (Figure 15A-C) are proposed to be a result of
M4 helix repositioning during gating and desensitization. Comparative CX-MS studies suggest the
M4 helix undergoes a twisting during channel activation followed by an outward bending during
desensitization. This proposed mechanism reflects the loss of crosslinking from the outer-most
lipid accessible side of the M4 helix (resting state residues 378-382, 384-389, Table 2, Figure 15A)
to more pronounced and concentrated crosslinking on the inner-most pore-facing side of M4 (open
state residues 383-385, Figure 15B) indicating a clockwise twist (top-down view) of the M4 helix.
Transition to desensitized state (residues 379, 384-385, Figure 15C) displays an increase in
crosslinking lower on M4 at residues closer towards the intracellular domain signifying the
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outward tilt or translation of the bottom portion of M4 helix. Taken together, state-dependent
crosslinking of M4 suggests a outward twisting motion as the helix allosteric transitions which is
consistent with general TMD movements observed between GlyR cryo structures stabilizing for
the same allosteric states.100 Cholesterol crosslinking within the portion of M4 nearing the M3M4 loop (bilayer lower leaflet region) is consistent with similar studies of nAChR195 showing Nterminal M4 cholesterol crosslinking. Our state-dependent cholesterol CX-MS study expands upon
the lipid-channel studies by being able to not only highlight the specific crosslinking locations
throughout the entire receptor, yet also distinguish the differential crosslinks in a state-dependent
manner.
Differential crosslinking patterns were also observed in the ECD nearing the
transmembrane domain. In initial CX-MS studies examining cholesterol crosslinking as a function
of cholesterol content,178 cholesterol crosslinking in the upper ECD is suggested to arise from azicholesterol accessibility to hydrophobic cavities during the detergent-based reconstitution process
following purification, and these crosslinked regions corresponded to predicted cholesterol
interaction locations. In resting state studies (Table 2, Figure 16A), the M2-M3 loop as well as the

Figure 15. M4 differential cholesterol crosslinking. Comparison of state-dependent cholesterol
crosslinking for the resting (A), open (B), and desensitized (C) conditions at > 40 mol percent
cholesterol within the M4 helix.
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Figure 16. ECD differential cholesterol crosslinking. Comparison of state-dependent
cholesterol crosslinking for the resting (A), open (B), and desensitized (C) conditions at > 40
mol percent cholesterol within the pre-M1 ECD region at the transmembrane interface.
“C loop” region of the outer β-sheet100 flanking above the characteristic Cys-loop were extensively
labeled, suggesting the incorporation and presence of cholesterol into the upper leaflet of the
bilayer along with a hydrophobic pocket between neighboring subunits. The crosslinked M2 -M3
loop residues adjoin a hydrophobic pocket at the ECD-TMD core244 in a region shown to harbor
transmembrane cavities that bind cholesterol,79 anesthetics,245 and correspond to predicted
cholesterol recognition motifs identified in proteins. 178 Cholesterol crosslinking within and near
the C Loop encompass the hydrophobic β-core conserved among pLGICs246 correlating with
determined CRAC/CARC interaction motifs. 178 This is a region of dynamic structural alterations
during channel gating and desensitization247 as well as Zn2+ modulation.248 Comparing apo-state
studies with conditions stabilizing the open state (Figure 16B) reveals a loss of M2-M3 loop
crosslinking (residues 272-274, 277-278, 280, Table 2) in conjunction with a shift of crosslinking
from exclusively outer β-sheet C Loop region to incorporate regions within the inner β-sheet
(residues 52-55, 58, 105-106, 116) and lower “Loop 2”249 that adjoin ECD-TMD interface,
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suggesting a reorientation of the ECD during gating that either exposes the lower crosslinked
residues identified or alters the hydrophobic cavity around/within the β-sheets. Juxtaposing
crosslinking in conditions that stabilized an open channel with desensitization (Figure 16C)
exposed nearly identical crosslinking with the exception of the loss of crosslinking in the lower
Loop 2 (residues 52-55, 58), suggesting allosteric repositioning of the lower ECD- upper TMD
interface during desensitization. Taken together, the ECD structure appears to be more similar
between conducting and desensitized GlyRs than apo-state channels and that more dynamic
movements are observed during channel activation in the lower ECD region where expansion from
the central pore is noted.75,100
The large intracellular M3-M4 loop was profoundly crosslinked by cholesterol in all three
allosteric states assayed with differential crosslinking patterns observed that clearly demonstrate
its intimacy with the lipid membrane as well as structural movements. Given that the M3-M4 loop
is often removed or is unresolved in the reported structures of pLGICs96,100,218,219 it is difficult to
speculate detailed structural movements of the M3-M4 loop as GlyR transitions between allosteric
states. Cholesterol crosslinking was identified in regions proximal to the M4 transmembrane helix
in all allosteric states (Figure 12). Contrasting crosslinking patterns from apo-state to stabilized
conducting-state studies (Figure 12A) show nearly identical patterns with the dramatic emergence
of crosslinking within central region of the M3-M4 loop (residues 327-341, 345-352, 356-357,
359-371) suggesting a reorientation of the M3-M4 loop during the gating process exposing
previously lipid-inaccessible residues. Allosteric shifting from open to desensitized states
illustrates the retention of cholesterol crosslinking at the ends (observed ubiquitously) and middle
of the M3-M4 loop (Figure 12A-B), suggesting minimal conformational rearrangement that
promotes less lipid accessibility. Taken together, the cholesterol crosslinking suggests three distinct
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allosteric conformations of the M3-M4 loop most notably through the emergence of profound
crosslinking in open and desensitized states exposing novel evidence pertaining to this elusive
region of GlyR.
In a similar manner, the unresolved post-M4 C-terminal tail of GlyR absent in structural
models100 was crosslinked by cholesterol in all three allosteric states assayed (Figures 13A-B,
previous publication).178 The smaller size and lack of structural resolution makes it difficult to
interpret results, however the crosslinked region of GlyR is assumed to be intimately associated
with

the

lipid

membrane. This

area

of

the

receptor

is

highly

dynamic

upon

activation/desensitization and implicated in Zn2+ modulation, highlighting the potential relevance
of the crosslinking data.248 Given the propensity GlyR to interact with intracellular proteins and be
targeted for post-translational modification250,251 these effects may be partially due to altered
interactions with lipids/accessibility or influenced by the lipid’s modulation of structure.
Cholesterol crosslinking between allosteric states was nearly identical in the C-terminal tail, with
subtle shifts in cholesterol labeling indicating no major differences (residues 415-417, 420-421).
This suggests minimal alterations in lipid accessibility of the post-M4 c-terminal tail of GlyR.
None the less, the crosslinking data sheds light on this unresolved portion of the receptor and may
have relevance to further elucidate this region.
Taken together, cholesterol dramatically associates and intimately interacts with α1 GlyR
in all domains, underlying its influence in membrane protein activity. Differential crosslinking
patterns of cholesterol were observed as a function of concentration and allosteric state
highlighting cholesterol’s role in channel allostery. In apo-state studies, cholesterol displayed
deferring interactions as a function of cholesterol/channel activity whereby unique patterns where
displayed corresponding to cholesterol chemical activity, suggesting two distinct apo-state GlyR
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structures. State-dependent cholesterol interactions exhibit differential labeling in regions of GlyR
that can suggest allosteric movements. Regions of the ECD, ECD-TMD interface, M3-M4 loop,
and M4 suggest more drastic structural movements from apo-state to open-state conducting
channels. This methodology can provide specific and accurate structural information in a state
dependent manner without potential detrimental structural alterations required for other high
resolution structure studies.
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CHAPTER 4: OVERVIEW AND FUTURE DIRECTION
4.1

Summary
The incorporation of tandem CX-MS analyses into biochemical workflows can drastically

expand the wealth of dynamic information gathered in a single experiment through generation of
sensitive yet accurately reproducible distance constraints occurring in physiological relevant
systems. Differential azi-cholesterol crosslinking patterns to GlyR were observed as a function of
cholesterol concentrations as well as between conditions stabilizing GlyR in its resting, open, or
desensitized states. This suggests either a change in lipid contacts with GlyR and/or GlyR
structural alterations that change hydrophobic pocket(s). Cholesterol interactions were observed
in the ECD, the ECD-TMD interface, the intracellular M3-M4 loop, and the M4 transmembrane
helix. Theses studies have identified dozens of cholesterol crosslinks in each trial using picomoles
of purified and reconstituted GlyR in varying lipid environments and allosteric conformations. The
CX-MS approach pioneered herein can be applied and implemented into a variety of biochemical
systems including other channels/transporters using any desired crosslinkers in varying functional
states, under native-like conditions, to widen the breadth of understanding of allostery.
Currently there are structures of GlyR bound to agonist/antagonist,100 ivermectin,100,218
and analgesic potentiators.243 However these studies have limitations modeling the highly
allosteric function of pLGICs as they require deletions and mutations for thermostability, are
bound to ligand, and often lack the presence of a bilayer. These limitations emphasize the need for
continued and improved methodologies to be able to offer precise models for each allosteric state
for full-length receptors in the presence of a physiologically-appropriate lipid bilayer. In current
GlyR models, the large intracellular M3-M4 loop as well as the post-M4 C-terminal tail are absent.
State-dependent comparative CX-MS studies offer the unique capability of complementing other
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high resolution methodologies to help refine dynamic changes of membrane proteins under
physiological conditions including the unresolved regions where other methods provide minimal,
if any, information. CX-MS can differentiate subtle structural movements throughout the protein,
including regions absent in current structures under physiological conditions and can drastically
enhance the allosteric understanding of membrane proteins.
As described in Chapter 2, cholesterol within a bilayer displays differential chemical
activity as a function of concentration. Chemically active cholesterol arises around and above ~33
mol% cholesterol within the lipid bilayer. The chemical activity of cholesterol in turn, alters the
channel activity of pLGICs, with elevated cholesterol levels increasing chemical activity, and this
effect plateaus at ~35 mol% cholesterol. Unique cholesterol crosslinking patterns where displayed
corresponding to cholesterol chemical activity, suggesting two distinct apo-state GlyR structures.
Cholesterol interactions, as evidenced by CX-MS, were observed in Chapter 3 to exhibit
state-dependent differential labeling in regions of GlyR including the ECD, ECD-TMD interface,
M3-M4 loop, and M4. These comparative studies highlight structural movements in this receptor
that occur in transitions from apo state to open state to desensitized state. This change in cholesterol
crosslinking patterns between allosteric states show structural movements between conformations
and define lipid-accessible hydrophobic regions of GlyR. This information complements the
limited availability of GlyR models that encompass allostery.100,243,252 Unresolved regions of
current truncated/altered models based on structural studies conducted in non-physiological
systems emphasizes the need for continued and improved methodologies to assist in generating
precise models for each allosteric state. CX-MS studies can elucidate subtle structural alterations
in a lipid-concentration and state-dependent manner throughout the entirety of the receptor
reconstituted in native bilayers.
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4.2

Future Studies
To further define the lipid accessible regions of the receptor and highlight potential specific

binding sites for different classes of lipids, analogous CX-MS investigations can be performed
using photoactivatable phospholipid crosslinkers. Anionic phospholipids like PA are required for
nAChR resting state stabilization (analogous to cholesterol dependence studies) whereby
membrane enrichment enhances receptor-mediated ion flux up to a given threshold (~12 mol%).86
The potential for specific phospholipid-GlyR interactions necessary for function can be discerned
in a state-dependent manner through comparison of PA and PC crosslinking at defined
concentrations (>12 mol%). PC can map general phospholipid/lipid accessibility to channels,
depicting general lipid bilayer interactions/accessibility which can differentiate hydrophobic
pocket interactions potentially observed in the cholesterol crosslinking studies. PA crosslinking
can map novel specific interactions or binding sites influencing channel activity through
differentiation of PC interactions which are assumed to highlight general bilayer accessibility.
In addition, in order to probe depth in the bilayer, the photoreactive diazirine motif can be
moved to either carbons more distant or near to the glycerol backbone, providing an effective way
to probe membrane depth and asymmetric depth-dependent lipid-protein interactions using
phospholipid crosslinkers. Although less defined, the incorporation of photoactivatable diazirine
motifs into sphingomyelin type lipids can map interactions to yet another class of lipids 253 to probe
specific concentration-dependent protein studies, such in the dimerization of SERT. 254 This
toolbox of crosslinkers can be utilized to map lipid-interaction profiles of other pLGIC members
and structural homologs.
Given that the MS methods we describe cannot quantify crosslinking events, additional
methodology needs to be developed to quantify crosslinking events. Such quantification will
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enrich the information of crosslinking datasets to not only provide the exact crosslinking site
location, but additionally determine the relative crosslinking frequency. Differentiating the
frequency of each crosslinking event can illuminate regions of prolonged lipid:protein interactions
(higher frequency events) contrasted against crosslinking regions representing cholesterol:GlyR
interactions that sparsely occur (low frequency events) yet are captured by the exceptional
sensitivity of the CX-MS methodology. The Cascio lab is developing a sensitive laser-induced
fluorescence microfluidic device that can be used as a parallel quantification tool to quantitate
tryptic peptdies (Davic, PhD thesis 2018). Peptides are derivatized on chip in immiscible
microdroplets with an amine-reactive fluorophore that only emits strongly when derivatized and
fluorescent emission is directly proportional to peptide concentration. Current studies are being
conducted to normalize fluorescent emission obtained from varying amino acids and peptides
(Apa, senior thesis, 2019).
The lipid-protein CX-MS studies will also be integrated with protein-protein CX-MS
studies initiated by Dr. Rathna Veeramachaneni and currently being conducted by Kayce Tomcho.
Both lipid-protein and protein-protein CX-MS studies provide complementary information to
further elucidate GlyR structure, specifically when crosslinking of both studies are mapped to
regions of models that may not be completely resolved in current models. The complementary
information can validate our determinations of regions being in closer proximity or intimately
associated with the lipid bilayer. The information obtained from both CX-MS studies supports
crosslinking data that appears artifactual or spurious when mapped to the current models. By
coupling the distance constraints created in the protein-protein CX-MS studies with the
lipid/bilayer accessibility of the lipid-protein CX-MS studies, regions of current GlyR models can
be more accurately defined, particularly in the regions absent in models. Overall, both lipid-protein
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and protein-protein CX-MS studies allow for the probing and elucidation of GlyR in membranes
at physiological-relevant different allosteric states which can complement crystallographic and
cryo-microscopy studies to provide a better understanding of these allosteric molecular machines
that are essential for cellular communication.
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APPENDIX: NMDA RECEPTOR DIMERIZATION

A.1

Overview
The NMDA receptor is a Ca 2+-permeable ligand-gated ion channel component of

excitatory neurotransmission within the CNS implicated in synaptic function, plasticity, learning,
and memory.255NMDA receptors form tetrameric complex assemblies of several homologous
subunits.256 The collaborative study wanted to discern if to regions of neighboring NMDA subunits
are in close physical proximity. Specific amino acids from each subunit were mutated to cysteines
to probe for intersubunit disulfide linkages.

A.2

Methodology
Gel bands were washed with 50:50 absolute methanol: 50 mM ammonium bicarbonate

twice for 40 min with gentle agitation (VWR Thermal Shake Touch, 900 rpm). Gel bands were
dehydrated by adding 500 L acetonitrile for 20 minutes. Acetonitrile was removed and gel bands
were dried in an Eppendorf 5301 Vacufuge Concentrator for approximately 15 minutes. Trypsin
solution (10 L at 20 g/mL in 50 mM ammonium bicarbonate) was added to gel bands and
incubated on ice for 15 minutes, then incubated overnight at 37˚C with gentle agitation (VWR
Thermal Shake Touch, 900 rpm); trypsin solution (10 L at 20 g/mL in 50 mM ammonium
bicarbonate) was added to gel bands an hour into incubation. The pH was adjusted to ~2 (5M HCl)
and pepsin solution (10 L at 1 mg/mL in H2O (pH~3) was added. Tubes were overnight at 37˚C
with gentle agitation. Digested peptides extracted into supernatant and transferred to VWR nonstick microcentrifuge tubes. Digested fragments were further extracted by incubating gel bands
twice for 30 minutes in 500 L of 0.1 % formic acid in 50:50 acetonitrile:H 2O. The supernatant
97

was collected and combined with initial supernatant. Digest extract solution was dried in an
Eppendorf 5301 Vacufuge Concentrator. Dried extract was reconstituted in 50 L of 0.1 % formic
acid in H 2O for 30 minutes with gentle agitation. The reconstituted peptides were run through
liquid chromatography-mass spectrometry (LCMS). Electrospray ionization quadrupole time-offlight mass spectrometry was done on the extracted peptides and measurements were taken using
an Agilent 6530 Q-TOF-MS with an Agilent HPLC-Chip II G4240-62006 ProtID-Chip-150.
Mobile phase compositions used were Solvent A (95 % H 2O, 5 % ACN, 0.1 % Formic acid) and
Solvent B (95 % ACN, 5 % H2O, 0.1 % Formic acid) The nanoflow elution gradient was developed
as follows at 0.50 µl/min of Solvent A (minute: percent A): 0.00: 95 %, 4.00: 10 %, 6.00: 70 %,
9.00: 50 %, 11.50: 95 %, 13.00: 95 %. The m/z range was 200-1700 m/z for MS analysis and 1002000 m/z for MSMS analysis. Data were processed using Agilent Qualitative Analysis Software
6.0 using the following parameters: 2 missed enzymatic cleavages, 20 ppm precursor ion/ 0.1 Da
product ion cutoff, and peptide modifications (oxidation and acrylamidation). For MS-MS
analysis, the extracted peptide samples were run again on the Agilent 6530 Q-TOF-MS, targeting
the specific mass-to-charge (m/z) ratio, charge, and retention time of the cross-linked peptides
identified in MS analysis. CID was used for MS-MS fragmentation following a linear increase in
collision energy by m/z using the equation: y=3.7x+2.5. CID was performed at + 0.2 min from
initial MS scan retention time of each crosslinked precursor ion identified. Measurements were
taken in triplicate from distinctive gel bands at molecular weights of crosslinked dimers.
Precursor/product ion pairing identified in >2 of 3 trials of mass ions unique to crosslinked
diheteromer gel band and not identified in controls (single subunit and enzymatic solution gel
band) were considered.
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A.3

Results
Following double enzymatic digestion of gel bands at molecular weights of the dimerized

subunits, MS analysis identified up to seven precursor ions from both trials indicative of disulfidelinked peptides and targeted for CID. MS-MS analysis identified product ions corresponding to
both individual subunit peptides and the diheteromer linkage (Figure 17, representative figure of
dataset).

Figure 17. MS analysis of crosslinked diheteromer. Representative tandem MS-MS fragmentation scan of
precursor m/z corresponding to crosslinked peptide pair produced from enzymatic double digestion. Fragmented
a, b and y product ions (labeled 1-6) stemming from the crosslinked peptide pair precursor ion were assigned to
product ions containing the disulfide crosslink between GluN1 and GluN2 (Diheteromer) as well as product ions
assigned to individual GluN1 and GluN2 peptides due to CID of the disulfide linkage.
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